[
  {
    "numberVerification": [
      {
        "longNumber": 281474976710655
      }
    ]
  }, 
  {
    "metaData": [
      {
        "idCounter": 135, 
        "elementCount": 14, 
        "name": "nodes", 
        "consistencyGroup": 1
      }, 
      {
        "idCounter": 135, 
        "elementCount": 37, 
        "name": "edges", 
        "consistencyGroup": 1
      }, 
      {
        "idCounter": 135, 
        "elementCount": 46, 
        "name": "supports", 
        "consistencyGroup": 1
      }, 
      {
        "idCounter": 135, 
        "elementCount": 38, 
        "name": "citations", 
        "consistencyGroup": 1
      }, 
      {
        "idCounter": 135, 
        "elementCount": 296, 
        "name": "edgeAttributes", 
        "consistencyGroup": 1
      }, 
      {
        "idCounter": 135, 
        "elementCount": 37, 
        "name": "edgeCitations", 
        "consistencyGroup": 1
      }, 
      {
        "idCounter": 135, 
        "elementCount": 37, 
        "name": "edgeSupports", 
        "consistencyGroup": 1
      }, 
      {
        "idCounter": 135, 
        "elementCount": 2, 
        "name": "networkAttributes", 
        "consistencyGroup": 1
      }, 
      {
        "idCounter": 135, 
        "elementCount": 36, 
        "name": "nodeAttributes", 
        "consistencyGroup": 1
      }
    ]
  }, 
  {
    "networkAttributes": [
      {
        "v": "TEST RAS Machine",
        "n": "name"
      }, 
      {
        "v": "desc",
        "n": "description"
      }
    ]
  }, 
  {
    "nodeAttributes": [
      {
        "v": "protein", 
        "po": 0, 
        "n": "type"
      }, 
      {
        "v": "http://identifiers.org/uniprot/P15056", 
        "po": 0, 
        "n": "UniProt"
      }, 
      {
        "v": "http://identifiers.org/hgnc/HGNC:1097", 
        "po": 0, 
        "n": "HGNC"
      }, 
      {
        "v": "proteinfamily", 
        "po": 1, 
        "n": "type"
      }, 
      {
        "v": "http://sorger.med.harvard.edu/indra/entities/ERK", 
        "po": 1, 
        "n": "BE"
      }, 
      {
        "v": "proteinfamily", 
        "po": 5, 
        "n": "type"
      }, 
      {
        "v": "http://sorger.med.harvard.edu/indra/entities/MEK", 
        "po": 5, 
        "n": "BE"
      }, 
      {
        "v": "protein", 
        "po": 50, 
        "n": "type"
      }, 
      {
        "v": "http://identifiers.org/uniprot/P01116", 
        "po": 50, 
        "n": "UniProt"
      }, 
      {
        "v": "http://identifiers.org/hgnc/HGNC:6407", 
        "po": 50, 
        "n": "HGNC"
      }, 
      {
        "v": "protein", 
        "po": 54, 
        "n": "type"
      }, 
      {
        "v": "http://identifiers.org/uniprot/P04049", 
        "po": 54, 
        "n": "UniProt"
      }, 
      {
        "v": "http://identifiers.org/hgnc/HGNC:9829", 
        "po": 54, 
        "n": "HGNC"
      }, 
      {
        "v": "bioprocess", 
        "po": 59, 
        "n": "type"
      }, 
      {
        "v": "http://identifiers.org/go/GO:0090398", 
        "po": 59, 
        "n": "GO"
      }, 
      {
        "v": "http://identifiers.org/mesh/D016922", 
        "po": 59, 
        "n": "MESH"
      }, 
      {
        "v": "protein", 
        "po": 63, 
        "n": "type"
      }, 
      {
        "v": "http://identifiers.org/uniprot/P00533", 
        "po": 63, 
        "n": "UniProt"
      }, 
      {
        "v": "http://identifiers.org/hgnc/HGNC:3236", 
        "po": 63, 
        "n": "HGNC"
      }, 
      {
        "v": "protein", 
        "po": 71, 
        "n": "type"
      }, 
      {
        "v": "http://identifiers.org/uniprot/Q01726", 
        "po": 71, 
        "n": "UniProt"
      }, 
      {
        "v": "http://identifiers.org/hgnc/HGNC:6929", 
        "po": 71, 
        "n": "HGNC"
      }, 
      {
        "v": "chemical", 
        "po": 81, 
        "n": "type"
      }, 
      {
        "v": "http://identifiers.org/chebi/CHEBI:75047", 
        "po": 81, 
        "n": "ChEBI"
      }, 
      {
        "v": "proteinfamily", 
        "po": 82, 
        "n": "type"
      }, 
      {
        "v": "http://sorger.med.harvard.edu/indra/entities/RAF", 
        "po": 82, 
        "n": "BE"
      }, 
      {
        "v": "chemical", 
        "po": 86, 
        "n": "type"
      }, 
      {
        "v": "http://identifiers.org/chebi/CHEBI:63637", 
        "po": 86, 
        "n": "ChEBI"
      }, 
      {
        "v": "http://identifiers.org/pubchem.compound/42611257", 
        "po": 86, 
        "n": "PubChem"
      }, 
      {
        "v": "chemical", 
        "po": 101, 
        "n": "type"
      }, 
      {
        "v": "http://identifiers.org/pubchem.compound/44462760", 
        "po": 101, 
        "n": "PubChem"
      }, 
      {
        "v": "chemical", 
        "po": 118, 
        "n": "type"
      }, 
      {
        "v": "http://identifiers.org/pubchem.compound/11707110", 
        "po": 118, 
        "n": "PubChem"
      }, 
      {
        "v": "protein", 
        "po": 131, 
        "n": "type"
      }, 
      {
        "v": "http://identifiers.org/uniprot/Q8IVT5", 
        "po": 131, 
        "n": "UniProt"
      }, 
      {
        "v": "http://identifiers.org/hgnc/HGNC:6465", 
        "po": 131, 
        "n": "HGNC"
      }
    ]
  }, 
  {
    "edgeAttributes": [
      {
        "v": "Activation(BRAF(muts: (G, 466, V)), ERK())", 
        "po": 2, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": \"466\", \"residue_from\": \"G\", \"residue_to\": \"V\"}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"ERK\", \"db_refs\": {\"TEXT\": \"ERK\", \"BE\": \"ERK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"6bf35494-4c76-43f2-bfe8-ff9ab1649876\", \"supported_by\": [\"68e0c377-cf08-4f78-ac3a-c091adb87f1f\", \"9c8af0f8-7add-4cdc-bee5-84f2ec571d0d\", \"801a10a6-8690-4c82-814e-2e107613971d\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}", 
        "po": 2, 
        "n": "INDRA json"
      }, 
      {
        "v": "Activation", 
        "po": 2, 
        "n": "type"
      }, 
      {
        "v": "positive", 
        "po": 2, 
        "n": "polarity"
      }, 
      {
        "v": "0.65", 
        "po": 2, 
        "n": "Belief score"
      }, 
      {
        "v": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
        "po": 2, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Activation", 
          "subj": {
            "name": "BRAF", 
            "mutations": [
              {
                "position": "466", 
                "residue_from": "G", 
                "residue_to": "V"
              }
            ], 
            "db_refs": {
              "TEXT": "BRAF", 
              "UP": "P15056", 
              "HGNC": "1097"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000459"
          }, 
          "obj": {
            "name": "ERK", 
            "db_refs": {
              "TEXT": "ERK", 
              "BE": "ERK"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000643"
          }, 
          "obj_activity": "activity", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
              "annotations": {
                "found_by": "Positive_activation_syntax_1_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "6bf35494-4c76-43f2-bfe8-ff9ab1649876", 
          "supported_by": [
            "68e0c377-cf08-4f78-ac3a-c091adb87f1f", 
            "9c8af0f8-7add-4cdc-bee5-84f2ec571d0d", 
            "801a10a6-8690-4c82-814e-2e107613971d"
          ], 
          "sbo": "http://identifiers.org/sbo/SBO:0000182"
        }, 
        "po": 2, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 2, 
        "n": "supportType"
      }, 
      {
        "v": "Activation(BRAF(muts: (G, 466, V)), MEK())", 
        "po": 6, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": \"466\", \"residue_from\": \"G\", \"residue_to\": \"V\"}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"MEK\", \"db_refs\": {\"TEXT\": \"MEK\", \"BE\": \"MEK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"d0fc25e0-ec0d-4864-a6fb-b5a27069da65\", \"supported_by\": [\"85cc2ebc-b977-4a04-9e34-5795a4f6f52d\", \"771097ad-717f-41da-b345-69c33dff8de4\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}", 
        "po": 6, 
        "n": "INDRA json"
      }, 
      {
        "v": "Activation", 
        "po": 6, 
        "n": "type"
      }, 
      {
        "v": "positive", 
        "po": 6, 
        "n": "polarity"
      }, 
      {
        "v": "0.65", 
        "po": 6, 
        "n": "Belief score"
      }, 
      {
        "v": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
        "po": 6, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Activation", 
          "subj": {
            "name": "BRAF", 
            "mutations": [
              {
                "position": "466", 
                "residue_from": "G", 
                "residue_to": "V"
              }
            ], 
            "db_refs": {
              "TEXT": "BRAF", 
              "UP": "P15056", 
              "HGNC": "1097"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000459"
          }, 
          "obj": {
            "name": "MEK", 
            "db_refs": {
              "TEXT": "MEK", 
              "BE": "MEK"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000643"
          }, 
          "obj_activity": "activity", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
              "annotations": {
                "found_by": "Positive_activation_syntax_1_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "d0fc25e0-ec0d-4864-a6fb-b5a27069da65", 
          "supported_by": [
            "85cc2ebc-b977-4a04-9e34-5795a4f6f52d", 
            "771097ad-717f-41da-b345-69c33dff8de4"
          ], 
          "sbo": "http://identifiers.org/sbo/SBO:0000182"
        }, 
        "po": 6, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 6, 
        "n": "supportType"
      }, 
      {
        "v": "Activation(BRAF(muts: (D, 594, A)), ERK())", 
        "po": 9, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": \"594\", \"residue_from\": \"D\", \"residue_to\": \"A\"}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"ERK\", \"db_refs\": {\"TEXT\": \"ERK\", \"BE\": \"ERK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"c08e01a8-1106-44cc-b3ed-faac092033fc\", \"supported_by\": [\"68e0c377-cf08-4f78-ac3a-c091adb87f1f\", \"9c8af0f8-7add-4cdc-bee5-84f2ec571d0d\", \"801a10a6-8690-4c82-814e-2e107613971d\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}", 
        "po": 9, 
        "n": "INDRA json"
      }, 
      {
        "v": "Activation", 
        "po": 9, 
        "n": "type"
      }, 
      {
        "v": "positive", 
        "po": 9, 
        "n": "polarity"
      }, 
      {
        "v": "0.65", 
        "po": 9, 
        "n": "Belief score"
      }, 
      {
        "v": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
        "po": 9, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Activation", 
          "subj": {
            "name": "BRAF", 
            "mutations": [
              {
                "position": "594", 
                "residue_from": "D", 
                "residue_to": "A"
              }
            ], 
            "db_refs": {
              "TEXT": "BRAF", 
              "UP": "P15056", 
              "HGNC": "1097"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000459"
          }, 
          "obj": {
            "name": "ERK", 
            "db_refs": {
              "TEXT": "ERK", 
              "BE": "ERK"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000643"
          }, 
          "obj_activity": "activity", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
              "annotations": {
                "found_by": "Positive_activation_syntax_1_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "c08e01a8-1106-44cc-b3ed-faac092033fc", 
          "supported_by": [
            "68e0c377-cf08-4f78-ac3a-c091adb87f1f", 
            "9c8af0f8-7add-4cdc-bee5-84f2ec571d0d", 
            "801a10a6-8690-4c82-814e-2e107613971d"
          ], 
          "sbo": "http://identifiers.org/sbo/SBO:0000182"
        }, 
        "po": 9, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 9, 
        "n": "supportType"
      }, 
      {
        "v": "Activation(BRAF(muts: (D, 594, A)), MEK())", 
        "po": 12, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": \"594\", \"residue_from\": \"D\", \"residue_to\": \"A\"}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"MEK\", \"db_refs\": {\"TEXT\": \"MEK\", \"BE\": \"MEK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"e3b4735f-b0dd-4a4a-a732-deb4c716b6a7\", \"supported_by\": [\"85cc2ebc-b977-4a04-9e34-5795a4f6f52d\", \"771097ad-717f-41da-b345-69c33dff8de4\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}", 
        "po": 12, 
        "n": "INDRA json"
      }, 
      {
        "v": "Activation", 
        "po": 12, 
        "n": "type"
      }, 
      {
        "v": "positive", 
        "po": 12, 
        "n": "polarity"
      }, 
      {
        "v": "0.65", 
        "po": 12, 
        "n": "Belief score"
      }, 
      {
        "v": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
        "po": 12, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Activation", 
          "subj": {
            "name": "BRAF", 
            "mutations": [
              {
                "position": "594", 
                "residue_from": "D", 
                "residue_to": "A"
              }
            ], 
            "db_refs": {
              "TEXT": "BRAF", 
              "UP": "P15056", 
              "HGNC": "1097"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000459"
          }, 
          "obj": {
            "name": "MEK", 
            "db_refs": {
              "TEXT": "MEK", 
              "BE": "MEK"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000643"
          }, 
          "obj_activity": "activity", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
              "annotations": {
                "found_by": "Positive_activation_syntax_1_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "e3b4735f-b0dd-4a4a-a732-deb4c716b6a7", 
          "supported_by": [
            "85cc2ebc-b977-4a04-9e34-5795a4f6f52d", 
            "771097ad-717f-41da-b345-69c33dff8de4"
          ], 
          "sbo": "http://identifiers.org/sbo/SBO:0000182"
        }, 
        "po": 12, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 12, 
        "n": "supportType"
      }, 
      {
        "v": "Activation(BRAF(muts: (D, 594, E)), ERK())", 
        "po": 15, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": \"594\", \"residue_from\": \"D\", \"residue_to\": \"E\"}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"ERK\", \"db_refs\": {\"TEXT\": \"ERK\", \"BE\": \"ERK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"43958f7b-e4f0-4c26-9072-37e6646b7d1c\", \"supported_by\": [\"801a10a6-8690-4c82-814e-2e107613971d\", \"9c8af0f8-7add-4cdc-bee5-84f2ec571d0d\", \"68e0c377-cf08-4f78-ac3a-c091adb87f1f\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}", 
        "po": 15, 
        "n": "INDRA json"
      }, 
      {
        "v": "Activation", 
        "po": 15, 
        "n": "type"
      }, 
      {
        "v": "positive", 
        "po": 15, 
        "n": "polarity"
      }, 
      {
        "v": "0.65", 
        "po": 15, 
        "n": "Belief score"
      }, 
      {
        "v": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
        "po": 15, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Activation", 
          "subj": {
            "name": "BRAF", 
            "mutations": [
              {
                "position": "594", 
                "residue_from": "D", 
                "residue_to": "E"
              }
            ], 
            "db_refs": {
              "TEXT": "BRAF", 
              "UP": "P15056", 
              "HGNC": "1097"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000459"
          }, 
          "obj": {
            "name": "ERK", 
            "db_refs": {
              "TEXT": "ERK", 
              "BE": "ERK"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000643"
          }, 
          "obj_activity": "activity", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
              "annotations": {
                "found_by": "Positive_activation_syntax_1_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "43958f7b-e4f0-4c26-9072-37e6646b7d1c", 
          "supported_by": [
            "801a10a6-8690-4c82-814e-2e107613971d", 
            "9c8af0f8-7add-4cdc-bee5-84f2ec571d0d", 
            "68e0c377-cf08-4f78-ac3a-c091adb87f1f"
          ], 
          "sbo": "http://identifiers.org/sbo/SBO:0000182"
        }, 
        "po": 15, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 15, 
        "n": "supportType"
      }, 
      {
        "v": "Activation(BRAF(muts: (D, 594, E)), MEK())", 
        "po": 18, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": \"594\", \"residue_from\": \"D\", \"residue_to\": \"E\"}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"MEK\", \"db_refs\": {\"TEXT\": \"MEK\", \"BE\": \"MEK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"3af54d2c-a4c4-41e2-b126-cb16b03f908a\", \"supported_by\": [\"771097ad-717f-41da-b345-69c33dff8de4\", \"85cc2ebc-b977-4a04-9e34-5795a4f6f52d\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}", 
        "po": 18, 
        "n": "INDRA json"
      }, 
      {
        "v": "Activation", 
        "po": 18, 
        "n": "type"
      }, 
      {
        "v": "positive", 
        "po": 18, 
        "n": "polarity"
      }, 
      {
        "v": "0.65", 
        "po": 18, 
        "n": "Belief score"
      }, 
      {
        "v": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
        "po": 18, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Activation", 
          "subj": {
            "name": "BRAF", 
            "mutations": [
              {
                "position": "594", 
                "residue_from": "D", 
                "residue_to": "E"
              }
            ], 
            "db_refs": {
              "TEXT": "BRAF", 
              "UP": "P15056", 
              "HGNC": "1097"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000459"
          }, 
          "obj": {
            "name": "MEK", 
            "db_refs": {
              "TEXT": "MEK", 
              "BE": "MEK"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000643"
          }, 
          "obj_activity": "activity", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
              "annotations": {
                "found_by": "Positive_activation_syntax_1_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "3af54d2c-a4c4-41e2-b126-cb16b03f908a", 
          "supported_by": [
            "771097ad-717f-41da-b345-69c33dff8de4", 
            "85cc2ebc-b977-4a04-9e34-5795a4f6f52d"
          ], 
          "sbo": "http://identifiers.org/sbo/SBO:0000182"
        }, 
        "po": 18, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 18, 
        "n": "supportType"
      }, 
      {
        "v": "Activation(BRAF(muts: (D, 594, G)), ERK())", 
        "po": 21, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": \"594\", \"residue_from\": \"D\", \"residue_to\": \"G\"}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"ERK\", \"db_refs\": {\"TEXT\": \"ERK\", \"BE\": \"ERK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"64a1f4a8-8d7d-4d28-b417-8abb818c33e2\", \"supported_by\": [\"9c8af0f8-7add-4cdc-bee5-84f2ec571d0d\", \"68e0c377-cf08-4f78-ac3a-c091adb87f1f\", \"801a10a6-8690-4c82-814e-2e107613971d\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}", 
        "po": 21, 
        "n": "INDRA json"
      }, 
      {
        "v": "Activation", 
        "po": 21, 
        "n": "type"
      }, 
      {
        "v": "positive", 
        "po": 21, 
        "n": "polarity"
      }, 
      {
        "v": "0.65", 
        "po": 21, 
        "n": "Belief score"
      }, 
      {
        "v": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
        "po": 21, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Activation", 
          "subj": {
            "name": "BRAF", 
            "mutations": [
              {
                "position": "594", 
                "residue_from": "D", 
                "residue_to": "G"
              }
            ], 
            "db_refs": {
              "TEXT": "BRAF", 
              "UP": "P15056", 
              "HGNC": "1097"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000459"
          }, 
          "obj": {
            "name": "ERK", 
            "db_refs": {
              "TEXT": "ERK", 
              "BE": "ERK"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000643"
          }, 
          "obj_activity": "activity", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
              "annotations": {
                "found_by": "Positive_activation_syntax_1_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "64a1f4a8-8d7d-4d28-b417-8abb818c33e2", 
          "supported_by": [
            "9c8af0f8-7add-4cdc-bee5-84f2ec571d0d", 
            "68e0c377-cf08-4f78-ac3a-c091adb87f1f", 
            "801a10a6-8690-4c82-814e-2e107613971d"
          ], 
          "sbo": "http://identifiers.org/sbo/SBO:0000182"
        }, 
        "po": 21, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 21, 
        "n": "supportType"
      }, 
      {
        "v": "Activation(BRAF(muts: (D, 594, G)), MEK())", 
        "po": 24, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": \"594\", \"residue_from\": \"D\", \"residue_to\": \"G\"}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"MEK\", \"db_refs\": {\"TEXT\": \"MEK\", \"BE\": \"MEK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"e1abe305-32b4-4a32-ad2b-08c7fc78cb5a\", \"supported_by\": [\"771097ad-717f-41da-b345-69c33dff8de4\", \"85cc2ebc-b977-4a04-9e34-5795a4f6f52d\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}", 
        "po": 24, 
        "n": "INDRA json"
      }, 
      {
        "v": "Activation", 
        "po": 24, 
        "n": "type"
      }, 
      {
        "v": "positive", 
        "po": 24, 
        "n": "polarity"
      }, 
      {
        "v": "0.65", 
        "po": 24, 
        "n": "Belief score"
      }, 
      {
        "v": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
        "po": 24, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Activation", 
          "subj": {
            "name": "BRAF", 
            "mutations": [
              {
                "position": "594", 
                "residue_from": "D", 
                "residue_to": "G"
              }
            ], 
            "db_refs": {
              "TEXT": "BRAF", 
              "UP": "P15056", 
              "HGNC": "1097"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000459"
          }, 
          "obj": {
            "name": "MEK", 
            "db_refs": {
              "TEXT": "MEK", 
              "BE": "MEK"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000643"
          }, 
          "obj_activity": "activity", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
              "annotations": {
                "found_by": "Positive_activation_syntax_1_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "e1abe305-32b4-4a32-ad2b-08c7fc78cb5a", 
          "supported_by": [
            "771097ad-717f-41da-b345-69c33dff8de4", 
            "85cc2ebc-b977-4a04-9e34-5795a4f6f52d"
          ], 
          "sbo": "http://identifiers.org/sbo/SBO:0000182"
        }, 
        "po": 24, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 24, 
        "n": "supportType"
      }, 
      {
        "v": "Activation(BRAF(muts: (D, 594, N)), ERK())", 
        "po": 27, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": \"594\", \"residue_from\": \"D\", \"residue_to\": \"N\"}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"ERK\", \"db_refs\": {\"TEXT\": \"ERK\", \"BE\": \"ERK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"98d42160-3c9c-4cd8-89da-8bcebb7caae3\", \"supported_by\": [\"68e0c377-cf08-4f78-ac3a-c091adb87f1f\", \"9c8af0f8-7add-4cdc-bee5-84f2ec571d0d\", \"801a10a6-8690-4c82-814e-2e107613971d\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}", 
        "po": 27, 
        "n": "INDRA json"
      }, 
      {
        "v": "Activation", 
        "po": 27, 
        "n": "type"
      }, 
      {
        "v": "positive", 
        "po": 27, 
        "n": "polarity"
      }, 
      {
        "v": "0.65", 
        "po": 27, 
        "n": "Belief score"
      }, 
      {
        "v": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
        "po": 27, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Activation", 
          "subj": {
            "name": "BRAF", 
            "mutations": [
              {
                "position": "594", 
                "residue_from": "D", 
                "residue_to": "N"
              }
            ], 
            "db_refs": {
              "TEXT": "BRAF", 
              "UP": "P15056", 
              "HGNC": "1097"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000459"
          }, 
          "obj": {
            "name": "ERK", 
            "db_refs": {
              "TEXT": "ERK", 
              "BE": "ERK"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000643"
          }, 
          "obj_activity": "activity", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
              "annotations": {
                "found_by": "Positive_activation_syntax_1_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "98d42160-3c9c-4cd8-89da-8bcebb7caae3", 
          "supported_by": [
            "68e0c377-cf08-4f78-ac3a-c091adb87f1f", 
            "9c8af0f8-7add-4cdc-bee5-84f2ec571d0d", 
            "801a10a6-8690-4c82-814e-2e107613971d"
          ], 
          "sbo": "http://identifiers.org/sbo/SBO:0000182"
        }, 
        "po": 27, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 27, 
        "n": "supportType"
      }, 
      {
        "v": "Activation(BRAF(muts: (D, 594, N)), MEK())", 
        "po": 30, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": \"594\", \"residue_from\": \"D\", \"residue_to\": \"N\"}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"MEK\", \"db_refs\": {\"TEXT\": \"MEK\", \"BE\": \"MEK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"f3a51c3f-75fd-486d-8563-d1db91eb39fe\", \"supported_by\": [\"771097ad-717f-41da-b345-69c33dff8de4\", \"85cc2ebc-b977-4a04-9e34-5795a4f6f52d\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}", 
        "po": 30, 
        "n": "INDRA json"
      }, 
      {
        "v": "Activation", 
        "po": 30, 
        "n": "type"
      }, 
      {
        "v": "positive", 
        "po": 30, 
        "n": "polarity"
      }, 
      {
        "v": "0.65", 
        "po": 30, 
        "n": "Belief score"
      }, 
      {
        "v": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
        "po": 30, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Activation", 
          "subj": {
            "name": "BRAF", 
            "mutations": [
              {
                "position": "594", 
                "residue_from": "D", 
                "residue_to": "N"
              }
            ], 
            "db_refs": {
              "TEXT": "BRAF", 
              "UP": "P15056", 
              "HGNC": "1097"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000459"
          }, 
          "obj": {
            "name": "MEK", 
            "db_refs": {
              "TEXT": "MEK", 
              "BE": "MEK"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000643"
          }, 
          "obj_activity": "activity", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
              "annotations": {
                "found_by": "Positive_activation_syntax_1_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "f3a51c3f-75fd-486d-8563-d1db91eb39fe", 
          "supported_by": [
            "771097ad-717f-41da-b345-69c33dff8de4", 
            "85cc2ebc-b977-4a04-9e34-5795a4f6f52d"
          ], 
          "sbo": "http://identifiers.org/sbo/SBO:0000182"
        }, 
        "po": 30, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 30, 
        "n": "supportType"
      }, 
      {
        "v": "Activation(BRAF(muts: (D, 594, V)), ERK())", 
        "po": 33, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": \"594\", \"residue_from\": \"D\", \"residue_to\": \"V\"}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"ERK\", \"db_refs\": {\"TEXT\": \"ERK\", \"BE\": \"ERK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"As we observed, D594V BRAF, even in the presence of CRAF, did not induce strong ERK activity.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}, {\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"00a6e12c-eba7-498b-a59c-a27a21a91d85\", \"supported_by\": [\"9c8af0f8-7add-4cdc-bee5-84f2ec571d0d\", \"801a10a6-8690-4c82-814e-2e107613971d\", \"68e0c377-cf08-4f78-ac3a-c091adb87f1f\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}", 
        "po": 33, 
        "n": "INDRA json"
      }, 
      {
        "v": "Activation", 
        "po": 33, 
        "n": "type"
      }, 
      {
        "v": "positive", 
        "po": 33, 
        "n": "polarity"
      }, 
      {
        "v": "0.86", 
        "po": 33, 
        "n": "Belief score"
      }, 
      {
        "v": "As we observed, D594V BRAF, even in the presence of CRAF, did not induce strong ERK activity.", 
        "po": 33, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Activation", 
          "subj": {
            "name": "BRAF", 
            "mutations": [
              {
                "position": "594", 
                "residue_from": "D", 
                "residue_to": "V"
              }
            ], 
            "db_refs": {
              "TEXT": "BRAF", 
              "UP": "P15056", 
              "HGNC": "1097"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000459"
          }, 
          "obj": {
            "name": "ERK", 
            "db_refs": {
              "TEXT": "ERK", 
              "BE": "ERK"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000643"
          }, 
          "obj_activity": "activity", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "As we observed, D594V BRAF, even in the presence of CRAF, did not induce strong ERK activity.", 
              "annotations": {
                "found_by": "Positive_activation_syntax_1_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }, 
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
              "annotations": {
                "found_by": "Positive_activation_syntax_1_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "00a6e12c-eba7-498b-a59c-a27a21a91d85", 
          "supported_by": [
            "9c8af0f8-7add-4cdc-bee5-84f2ec571d0d", 
            "801a10a6-8690-4c82-814e-2e107613971d", 
            "68e0c377-cf08-4f78-ac3a-c091adb87f1f"
          ], 
          "sbo": "http://identifiers.org/sbo/SBO:0000182"
        }, 
        "po": 33, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 33, 
        "n": "supportType"
      }, 
      {
        "v": "Activation(BRAF(muts: (D, 594, V)), MEK())", 
        "po": 37, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": \"594\", \"residue_from\": \"D\", \"residue_to\": \"V\"}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"MEK\", \"db_refs\": {\"TEXT\": \"MEK\", \"BE\": \"MEK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"581301ea-cbaf-4c59-9d5a-9405a743962f\", \"supported_by\": [\"771097ad-717f-41da-b345-69c33dff8de4\", \"85cc2ebc-b977-4a04-9e34-5795a4f6f52d\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}", 
        "po": 37, 
        "n": "INDRA json"
      }, 
      {
        "v": "Activation", 
        "po": 37, 
        "n": "type"
      }, 
      {
        "v": "positive", 
        "po": 37, 
        "n": "polarity"
      }, 
      {
        "v": "0.65", 
        "po": 37, 
        "n": "Belief score"
      }, 
      {
        "v": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
        "po": 37, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Activation", 
          "subj": {
            "name": "BRAF", 
            "mutations": [
              {
                "position": "594", 
                "residue_from": "D", 
                "residue_to": "V"
              }
            ], 
            "db_refs": {
              "TEXT": "BRAF", 
              "UP": "P15056", 
              "HGNC": "1097"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000459"
          }, 
          "obj": {
            "name": "MEK", 
            "db_refs": {
              "TEXT": "MEK", 
              "BE": "MEK"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000643"
          }, 
          "obj_activity": "activity", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
              "annotations": {
                "found_by": "Positive_activation_syntax_1_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "581301ea-cbaf-4c59-9d5a-9405a743962f", 
          "supported_by": [
            "771097ad-717f-41da-b345-69c33dff8de4", 
            "85cc2ebc-b977-4a04-9e34-5795a4f6f52d"
          ], 
          "sbo": "http://identifiers.org/sbo/SBO:0000182"
        }, 
        "po": 37, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 37, 
        "n": "supportType"
      }, 
      {
        "v": "Activation(BRAF(muts: (G, 596, C)), ERK())", 
        "po": 40, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": \"596\", \"residue_from\": \"G\", \"residue_to\": \"C\"}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"ERK\", \"db_refs\": {\"TEXT\": \"ERK\", \"BE\": \"ERK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"3492dad4-9228-4e61-ad08-28c2c8ababb3\", \"supported_by\": [\"9c8af0f8-7add-4cdc-bee5-84f2ec571d0d\", \"801a10a6-8690-4c82-814e-2e107613971d\", \"68e0c377-cf08-4f78-ac3a-c091adb87f1f\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}", 
        "po": 40, 
        "n": "INDRA json"
      }, 
      {
        "v": "Activation", 
        "po": 40, 
        "n": "type"
      }, 
      {
        "v": "positive", 
        "po": 40, 
        "n": "polarity"
      }, 
      {
        "v": "0.65", 
        "po": 40, 
        "n": "Belief score"
      }, 
      {
        "v": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
        "po": 40, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Activation", 
          "subj": {
            "name": "BRAF", 
            "mutations": [
              {
                "position": "596", 
                "residue_from": "G", 
                "residue_to": "C"
              }
            ], 
            "db_refs": {
              "TEXT": "BRAF", 
              "UP": "P15056", 
              "HGNC": "1097"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000459"
          }, 
          "obj": {
            "name": "ERK", 
            "db_refs": {
              "TEXT": "ERK", 
              "BE": "ERK"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000643"
          }, 
          "obj_activity": "activity", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
              "annotations": {
                "found_by": "Positive_activation_syntax_1_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "3492dad4-9228-4e61-ad08-28c2c8ababb3", 
          "supported_by": [
            "9c8af0f8-7add-4cdc-bee5-84f2ec571d0d", 
            "801a10a6-8690-4c82-814e-2e107613971d", 
            "68e0c377-cf08-4f78-ac3a-c091adb87f1f"
          ], 
          "sbo": "http://identifiers.org/sbo/SBO:0000182"
        }, 
        "po": 40, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 40, 
        "n": "supportType"
      }, 
      {
        "v": "Activation(BRAF(muts: (G, 596, C)), MEK())", 
        "po": 43, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": \"596\", \"residue_from\": \"G\", \"residue_to\": \"C\"}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"MEK\", \"db_refs\": {\"TEXT\": \"MEK\", \"BE\": \"MEK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"a714426b-948a-436a-9bdb-47c007f8bc8e\", \"supported_by\": [\"85cc2ebc-b977-4a04-9e34-5795a4f6f52d\", \"771097ad-717f-41da-b345-69c33dff8de4\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}", 
        "po": 43, 
        "n": "INDRA json"
      }, 
      {
        "v": "Activation", 
        "po": 43, 
        "n": "type"
      }, 
      {
        "v": "positive", 
        "po": 43, 
        "n": "polarity"
      }, 
      {
        "v": "0.65", 
        "po": 43, 
        "n": "Belief score"
      }, 
      {
        "v": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
        "po": 43, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Activation", 
          "subj": {
            "name": "BRAF", 
            "mutations": [
              {
                "position": "596", 
                "residue_from": "G", 
                "residue_to": "C"
              }
            ], 
            "db_refs": {
              "TEXT": "BRAF", 
              "UP": "P15056", 
              "HGNC": "1097"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000459"
          }, 
          "obj": {
            "name": "MEK", 
            "db_refs": {
              "TEXT": "MEK", 
              "BE": "MEK"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000643"
          }, 
          "obj_activity": "activity", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
              "annotations": {
                "found_by": "Positive_activation_syntax_1_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "a714426b-948a-436a-9bdb-47c007f8bc8e", 
          "supported_by": [
            "85cc2ebc-b977-4a04-9e34-5795a4f6f52d", 
            "771097ad-717f-41da-b345-69c33dff8de4"
          ], 
          "sbo": "http://identifiers.org/sbo/SBO:0000182"
        }, 
        "po": 43, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 43, 
        "n": "supportType"
      }, 
      {
        "v": "Activation(BRAF(muts: (V, 600, E)), ERK())", 
        "po": 46, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": \"600\", \"residue_from\": \"V\", \"residue_to\": \"E\"}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"ERK\", \"db_refs\": {\"TEXT\": \"MAPK\", \"BE\": \"ERK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28986151\", \"text\": \"The BRAF V600E mutation activates MAPK, affecting cell proliferation, differentiation, and survival.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}, {\"source_api\": \"reach\", \"pmid\": \"28986151\", \"text\": \"BRAF V600E mutation has been reported to abnormally activate MAPK signal pathway.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"6cb10cca-7d40-48b6-ba4e-12766a7d4029\", \"supported_by\": [\"68e0c377-cf08-4f78-ac3a-c091adb87f1f\", \"801a10a6-8690-4c82-814e-2e107613971d\", \"9c8af0f8-7add-4cdc-bee5-84f2ec571d0d\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}", 
        "po": 46, 
        "n": "INDRA json"
      }, 
      {
        "v": "Activation", 
        "po": 46, 
        "n": "type"
      }, 
      {
        "v": "positive", 
        "po": 46, 
        "n": "polarity"
      }, 
      {
        "v": "0.86", 
        "po": 46, 
        "n": "Belief score"
      }, 
      {
        "v": "The BRAF V600E mutation activates MAPK, affecting cell proliferation, differentiation, and survival.", 
        "po": 46, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Activation", 
          "subj": {
            "name": "BRAF", 
            "mutations": [
              {
                "position": "600", 
                "residue_from": "V", 
                "residue_to": "E"
              }
            ], 
            "db_refs": {
              "TEXT": "BRAF", 
              "UP": "P15056", 
              "HGNC": "1097"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000459"
          }, 
          "obj": {
            "name": "ERK", 
            "db_refs": {
              "TEXT": "MAPK", 
              "BE": "ERK"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000643"
          }, 
          "obj_activity": "activity", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28986151", 
              "text": "The BRAF V600E mutation activates MAPK, affecting cell proliferation, differentiation, and survival.", 
              "annotations": {
                "found_by": "Positive_activation_syntax_1_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }, 
            {
              "source_api": "reach", 
              "pmid": "28986151", 
              "text": "BRAF V600E mutation has been reported to abnormally activate MAPK signal pathway.", 
              "annotations": {
                "found_by": "Positive_activation_syntax_1_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "6cb10cca-7d40-48b6-ba4e-12766a7d4029", 
          "supported_by": [
            "68e0c377-cf08-4f78-ac3a-c091adb87f1f", 
            "801a10a6-8690-4c82-814e-2e107613971d", 
            "9c8af0f8-7add-4cdc-bee5-84f2ec571d0d"
          ], 
          "sbo": "http://identifiers.org/sbo/SBO:0000182"
        }, 
        "po": 46, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 46, 
        "n": "supportType"
      }, 
      {
        "v": "Activation(BRAF(muts: (None, None, None)), KRAS())", 
        "po": 51, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": null, \"residue_from\": null, \"residue_to\": null}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"KRAS\", \"db_refs\": {\"TEXT\": \"KRAS\", \"UP\": \"P01116\", \"HGNC\": \"6407\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"This result may explain why H1666 and H508 cells are more sensitive to Trametinib than to Selumetinib, as BRAF mutations in these cell lines activate the ERK pathway in a CRAF dependent manner, similarly to KRAS mutated cells.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_7_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"5a1dfdf7-5f79-4a9c-a753-37c2ec76b177\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}", 
        "po": 51, 
        "n": "INDRA json"
      }, 
      {
        "v": "Activation", 
        "po": 51, 
        "n": "type"
      }, 
      {
        "v": "positive", 
        "po": 51, 
        "n": "polarity"
      }, 
      {
        "v": "0.65", 
        "po": 51, 
        "n": "Belief score"
      }, 
      {
        "v": "This result may explain why H1666 and H508 cells are more sensitive to Trametinib than to Selumetinib, as BRAF mutations in these cell lines activate the ERK pathway in a CRAF dependent manner, similarly to KRAS mutated cells.", 
        "po": 51, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Activation", 
          "subj": {
            "name": "BRAF", 
            "mutations": [
              {
                "position": null, 
                "residue_from": null, 
                "residue_to": null
              }
            ], 
            "db_refs": {
              "TEXT": "BRAF", 
              "UP": "P15056", 
              "HGNC": "1097"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000459"
          }, 
          "obj": {
            "name": "KRAS", 
            "db_refs": {
              "TEXT": "KRAS", 
              "UP": "P01116", 
              "HGNC": "6407"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000643"
          }, 
          "obj_activity": "activity", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "This result may explain why H1666 and H508 cells are more sensitive to Trametinib than to Selumetinib, as BRAF mutations in these cell lines activate the ERK pathway in a CRAF dependent manner, similarly to KRAS mutated cells.", 
              "annotations": {
                "found_by": "Positive_activation_syntax_7_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "5a1dfdf7-5f79-4a9c-a753-37c2ec76b177", 
          "sbo": "http://identifiers.org/sbo/SBO:0000182"
        }, 
        "po": 51, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 51, 
        "n": "supportType"
      }, 
      {
        "v": "Activation(BRAF(muts: (None, None, None)), RAF1())", 
        "po": 55, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": null, \"residue_from\": null, \"residue_to\": null}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"RAF1\", \"db_refs\": {\"TEXT\": \"CRAF\", \"UP\": \"P04049\", \"HGNC\": \"9829\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"A clinically relevant dose of Dabrafenib, a type I RAF-inhibitor, in HEK293T cells reduced ERK activity induced by BRAF mutations conferring high kinase activity in the presence and absence of CRAF.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}, {\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"This result may explain why H1666 and H508 cells are more sensitive to Trametinib than to Selumetinib, as BRAF mutations in these cell lines activate the ERK pathway in a CRAF dependent manner, similarly to KRAS mutated cells.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"389a79fd-59a9-4948-b8e4-c98a525b11fc\", \"supported_by\": [\"b939dd60-2425-4db4-8d27-88782444892e\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}", 
        "po": 55, 
        "n": "INDRA json"
      }, 
      {
        "v": "Activation", 
        "po": 55, 
        "n": "type"
      }, 
      {
        "v": "positive", 
        "po": 55, 
        "n": "polarity"
      }, 
      {
        "v": "0.86", 
        "po": 55, 
        "n": "Belief score"
      }, 
      {
        "v": "A clinically relevant dose of Dabrafenib, a type I RAF-inhibitor, in HEK293T cells reduced ERK activity induced by BRAF mutations conferring high kinase activity in the presence and absence of CRAF.", 
        "po": 55, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Activation", 
          "subj": {
            "name": "BRAF", 
            "mutations": [
              {
                "position": null, 
                "residue_from": null, 
                "residue_to": null
              }
            ], 
            "db_refs": {
              "TEXT": "BRAF", 
              "UP": "P15056", 
              "HGNC": "1097"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000459"
          }, 
          "obj": {
            "name": "RAF1", 
            "db_refs": {
              "TEXT": "CRAF", 
              "UP": "P04049", 
              "HGNC": "9829"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000643"
          }, 
          "obj_activity": "activity", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "A clinically relevant dose of Dabrafenib, a type I RAF-inhibitor, in HEK293T cells reduced ERK activity induced by BRAF mutations conferring high kinase activity in the presence and absence of CRAF.", 
              "annotations": {
                "found_by": "Positive_activation_syntax_1_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }, 
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "This result may explain why H1666 and H508 cells are more sensitive to Trametinib than to Selumetinib, as BRAF mutations in these cell lines activate the ERK pathway in a CRAF dependent manner, similarly to KRAS mutated cells.", 
              "annotations": {
                "found_by": "Positive_activation_syntax_1_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "389a79fd-59a9-4948-b8e4-c98a525b11fc", 
          "supported_by": [
            "b939dd60-2425-4db4-8d27-88782444892e"
          ], 
          "sbo": "http://identifiers.org/sbo/SBO:0000182"
        }, 
        "po": 55, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 55, 
        "n": "supportType"
      }, 
      {
        "v": "Activation(BRAF(), senescence())", 
        "po": 60, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"BRAF\", \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"senescence\", \"db_refs\": {\"GO\": \"GO:0090398\", \"TEXT\": \"senescence\", \"MESH\": \"D016922\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28986151\", \"text\": \"Some studies also found that constitutive BRAF activity induces MAPK activity and glioma genesis in xenografted mice but eventually leads to tumour senescence.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_7_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"dc7fb5b6-1ac9-4a2c-ba35-17627337fdf8\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}", 
        "po": 60, 
        "n": "INDRA json"
      }, 
      {
        "v": "Activation", 
        "po": 60, 
        "n": "type"
      }, 
      {
        "v": "positive", 
        "po": 60, 
        "n": "polarity"
      }, 
      {
        "v": "0.65", 
        "po": 60, 
        "n": "Belief score"
      }, 
      {
        "v": "Some studies also found that constitutive BRAF activity induces MAPK activity and glioma genesis in xenografted mice but eventually leads to tumour senescence.", 
        "po": 60, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Activation", 
          "subj": {
            "name": "BRAF", 
            "db_refs": {
              "TEXT": "BRAF", 
              "UP": "P15056", 
              "HGNC": "1097"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000459"
          }, 
          "obj": {
            "name": "senescence", 
            "db_refs": {
              "GO": "GO:0090398", 
              "TEXT": "senescence", 
              "MESH": "D016922"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000643"
          }, 
          "obj_activity": "activity", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28986151", 
              "text": "Some studies also found that constitutive BRAF activity induces MAPK activity and glioma genesis in xenografted mice but eventually leads to tumour senescence.", 
              "annotations": {
                "found_by": "Positive_activation_syntax_7_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "dc7fb5b6-1ac9-4a2c-ba35-17627337fdf8", 
          "sbo": "http://identifiers.org/sbo/SBO:0000182"
        }, 
        "po": 60, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 60, 
        "n": "supportType"
      }, 
      {
        "v": "Activation(EGFR(), BRAF())", 
        "po": 64, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"EGFR\", \"db_refs\": {\"TEXT\": \"EGFR\", \"UP\": \"P00533\", \"HGNC\": \"3236\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"BRAF\", \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28974625\", \"text\": \"Retraction : EGFR Mediated Reactivation of MAPK Signaling Induces Acquired Resistance to GSK2118436 in BRAF V600E-Mutant NSCLC Cell Lines.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"b202c476-e5de-44a5-bacc-599a21695a36\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}", 
        "po": 64, 
        "n": "INDRA json"
      }, 
      {
        "v": "Activation", 
        "po": 64, 
        "n": "type"
      }, 
      {
        "v": "positive", 
        "po": 64, 
        "n": "polarity"
      }, 
      {
        "v": "0.65", 
        "po": 64, 
        "n": "Belief score"
      }, 
      {
        "v": "Retraction : EGFR Mediated Reactivation of MAPK Signaling Induces Acquired Resistance to GSK2118436 in BRAF V600E-Mutant NSCLC Cell Lines.", 
        "po": 64, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Activation", 
          "subj": {
            "name": "EGFR", 
            "db_refs": {
              "TEXT": "EGFR", 
              "UP": "P00533", 
              "HGNC": "3236"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000459"
          }, 
          "obj": {
            "name": "BRAF", 
            "db_refs": {
              "TEXT": "BRAF", 
              "UP": "P15056", 
              "HGNC": "1097"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000643"
          }, 
          "obj_activity": "activity", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28974625", 
              "text": "Retraction : EGFR Mediated Reactivation of MAPK Signaling Induces Acquired Resistance to GSK2118436 in BRAF V600E-Mutant NSCLC Cell Lines.", 
              "annotations": {
                "found_by": "Positive_activation_syntax_1_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "b202c476-e5de-44a5-bacc-599a21695a36", 
          "sbo": "http://identifiers.org/sbo/SBO:0000182"
        }, 
        "po": 64, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 64, 
        "n": "supportType"
      }, 
      {
        "v": "Activation(ERK(), RAF1())", 
        "po": 67, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"ERK\", \"db_refs\": {\"TEXT\": \"ERK\", \"BE\": \"ERK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"RAF1\", \"db_refs\": {\"TEXT\": \"CRAF\", \"UP\": \"P04049\", \"HGNC\": \"9829\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"A clinically relevant dose of Dabrafenib, a type I RAF-inhibitor, in HEK293T cells reduced ERK activity induced by BRAF mutations conferring high kinase activity in the presence and absence of CRAF.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}, {\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"In addition, combined Dabrafenib and Trametinib treatment inhibited Dabrafenib induced ERK activation in CRAF overexpressing monotransfectants.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_3_noun\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"c56399b1-5c85-406c-8609-f68b731adecd\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}", 
        "po": 67, 
        "n": "INDRA json"
      }, 
      {
        "v": "Activation", 
        "po": 67, 
        "n": "type"
      }, 
      {
        "v": "positive", 
        "po": 67, 
        "n": "polarity"
      }, 
      {
        "v": "0.86", 
        "po": 67, 
        "n": "Belief score"
      }, 
      {
        "v": "A clinically relevant dose of Dabrafenib, a type I RAF-inhibitor, in HEK293T cells reduced ERK activity induced by BRAF mutations conferring high kinase activity in the presence and absence of CRAF.", 
        "po": 67, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Activation", 
          "subj": {
            "name": "ERK", 
            "db_refs": {
              "TEXT": "ERK", 
              "BE": "ERK"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000459"
          }, 
          "obj": {
            "name": "RAF1", 
            "db_refs": {
              "TEXT": "CRAF", 
              "UP": "P04049", 
              "HGNC": "9829"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000643"
          }, 
          "obj_activity": "activity", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "A clinically relevant dose of Dabrafenib, a type I RAF-inhibitor, in HEK293T cells reduced ERK activity induced by BRAF mutations conferring high kinase activity in the presence and absence of CRAF.", 
              "annotations": {
                "found_by": "Positive_activation_syntax_1_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }, 
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "In addition, combined Dabrafenib and Trametinib treatment inhibited Dabrafenib induced ERK activation in CRAF overexpressing monotransfectants.", 
              "annotations": {
                "found_by": "Positive_activation_syntax_3_noun"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "c56399b1-5c85-406c-8609-f68b731adecd", 
          "sbo": "http://identifiers.org/sbo/SBO:0000182"
        }, 
        "po": 67, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 67, 
        "n": "supportType"
      }, 
      {
        "v": "Activation(MC1R(), BRAF())", 
        "po": 72, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"MC1R\", \"db_refs\": {\"TEXT\": \"MC1R\", \"UP\": \"Q01726\", \"HGNC\": \"6929\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"BRAF\", \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28916587\", \"text\": \"Palmitoylation deficient MC1R variants accelerate BRAF (V60E)-driven melanomagenesis.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"2fc7fda0-15b0-414e-8ff7-025f45cb8c0b\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}", 
        "po": 72, 
        "n": "INDRA json"
      }, 
      {
        "v": "Activation", 
        "po": 72, 
        "n": "type"
      }, 
      {
        "v": "positive", 
        "po": 72, 
        "n": "polarity"
      }, 
      {
        "v": "0.65", 
        "po": 72, 
        "n": "Belief score"
      }, 
      {
        "v": "Palmitoylation deficient MC1R variants accelerate BRAF (V60E)-driven melanomagenesis.", 
        "po": 72, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Activation", 
          "subj": {
            "name": "MC1R", 
            "db_refs": {
              "TEXT": "MC1R", 
              "UP": "Q01726", 
              "HGNC": "6929"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000459"
          }, 
          "obj": {
            "name": "BRAF", 
            "db_refs": {
              "TEXT": "BRAF", 
              "UP": "P15056", 
              "HGNC": "1097"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000643"
          }, 
          "obj_activity": "activity", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28916587", 
              "text": "Palmitoylation deficient MC1R variants accelerate BRAF (V60E)-driven melanomagenesis.", 
              "annotations": {
                "found_by": "Positive_activation_syntax_1_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "2fc7fda0-15b0-414e-8ff7-025f45cb8c0b", 
          "sbo": "http://identifiers.org/sbo/SBO:0000182"
        }, 
        "po": 72, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 72, 
        "n": "supportType"
      }, 
      {
        "v": "Activation(RAF1(), ERK())", 
        "po": 75, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"RAF1\", \"db_refs\": {\"TEXT\": \"CRAF\", \"UP\": \"P04049\", \"HGNC\": \"9829\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"ERK\", \"db_refs\": {\"TEXT\": \"ERK\", \"BE\": \"ERK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"In HEK293T cells, Trametinib modestly decreased ERK activity induced by BRAF mutations conferring elevated kinase activity while strongly inhibited kinase impaired BRAF and CRAF induced ERK activation.\", \"annotations\": {\"found_by\": \"Positive_early_activation\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}, {\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"A recent study revealed the superior efficacy of Trametinib versus several other MEK-inhibitors in cells with KRAS mutations and CRAF mediated ERK pathway activation [XREF_BIBR].\", \"annotations\": {\"found_by\": \"Positive_early_activation\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}, {\"source_api\": \"reach\", \"pmid\": \"28953887\", \"text\": \"In BRAFi resistant cells, PAKs phosphorylate CRAF and MEK to reactivate ERK.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"65ffaa64-8419-4f74-818a-d43992319f17\", \"supported_by\": [\"801a10a6-8690-4c82-814e-2e107613971d\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}", 
        "po": 75, 
        "n": "INDRA json"
      }, 
      {
        "v": "Activation", 
        "po": 75, 
        "n": "type"
      }, 
      {
        "v": "positive", 
        "po": 75, 
        "n": "polarity"
      }, 
      {
        "v": "0.92", 
        "po": 75, 
        "n": "Belief score"
      }, 
      {
        "v": "In HEK293T cells, Trametinib modestly decreased ERK activity induced by BRAF mutations conferring elevated kinase activity while strongly inhibited kinase impaired BRAF and CRAF induced ERK activation.", 
        "po": 75, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Activation", 
          "subj": {
            "name": "RAF1", 
            "db_refs": {
              "TEXT": "CRAF", 
              "UP": "P04049", 
              "HGNC": "9829"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000459"
          }, 
          "obj": {
            "name": "ERK", 
            "db_refs": {
              "TEXT": "ERK", 
              "BE": "ERK"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000643"
          }, 
          "obj_activity": "activity", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "In HEK293T cells, Trametinib modestly decreased ERK activity induced by BRAF mutations conferring elevated kinase activity while strongly inhibited kinase impaired BRAF and CRAF induced ERK activation.", 
              "annotations": {
                "found_by": "Positive_early_activation"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }, 
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "A recent study revealed the superior efficacy of Trametinib versus several other MEK-inhibitors in cells with KRAS mutations and CRAF mediated ERK pathway activation [XREF_BIBR].", 
              "annotations": {
                "found_by": "Positive_early_activation"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }, 
            {
              "source_api": "reach", 
              "pmid": "28953887", 
              "text": "In BRAFi resistant cells, PAKs phosphorylate CRAF and MEK to reactivate ERK.", 
              "annotations": {
                "found_by": "Positive_activation_syntax_1_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "65ffaa64-8419-4f74-818a-d43992319f17", 
          "supported_by": [
            "801a10a6-8690-4c82-814e-2e107613971d"
          ], 
          "sbo": "http://identifiers.org/sbo/SBO:0000182"
        }, 
        "po": 75, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 75, 
        "n": "supportType"
      }, 
      {
        "v": "Activation(RAF_inhibitors(), RAF())", 
        "po": 83, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"RAF_inhibitors\", \"db_refs\": {\"TEXT\": \"RAF inhibitors\", \"CHEBI\": \"CHEBI:75047\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"RAF\", \"db_refs\": {\"TEXT\": \"RAF\", \"BE\": \"RAF\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28951457\", \"text\": \"Currently approved RAF inhibitors inhibit RAF monomers but not dimers.\", \"annotations\": {\"found_by\": \"Negative_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"5ba5fe59-5973-48f3-871c-dbf2e2108436\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}", 
        "po": 83, 
        "n": "INDRA json"
      }, 
      {
        "v": "Activation", 
        "po": 83, 
        "n": "type"
      }, 
      {
        "v": "positive", 
        "po": 83, 
        "n": "polarity"
      }, 
      {
        "v": "0.65", 
        "po": 83, 
        "n": "Belief score"
      }, 
      {
        "v": "Currently approved RAF inhibitors inhibit RAF monomers but not dimers.", 
        "po": 83, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Activation", 
          "subj": {
            "name": "RAF_inhibitors", 
            "db_refs": {
              "TEXT": "RAF inhibitors", 
              "CHEBI": "CHEBI:75047"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000459"
          }, 
          "obj": {
            "name": "RAF", 
            "db_refs": {
              "TEXT": "RAF", 
              "BE": "RAF"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000643"
          }, 
          "obj_activity": "activity", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28951457", 
              "text": "Currently approved RAF inhibitors inhibit RAF monomers but not dimers.", 
              "annotations": {
                "found_by": "Negative_activation_syntax_1_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "5ba5fe59-5973-48f3-871c-dbf2e2108436", 
          "sbo": "http://identifiers.org/sbo/SBO:0000182"
        }, 
        "po": 83, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 83, 
        "n": "supportType"
      }, 
      {
        "v": "Activation(vemurafenib(), BRAF())", 
        "po": 87, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Activation\", \"subj\": {\"name\": \"vemurafenib\", \"db_refs\": {\"TEXT\": \"vemurafenib\", \"CHEBI\": \"CHEBI:63637\", \"PUBCHEM\": \"42611257\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000459\"}, \"obj\": {\"name\": \"BRAF\", \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000643\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28963614\", \"text\": \"From November 2012 to October 2015 we have selected 43 BRAF mutated, metastatic melanoma patients, treated with vemurafenib.\", \"annotations\": {\"found_by\": \"Positive_activation_surface_treated_with\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"2157d53e-94d4-424c-99eb-754e1beb7a6d\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}", 
        "po": 87, 
        "n": "INDRA json"
      }, 
      {
        "v": "Activation", 
        "po": 87, 
        "n": "type"
      }, 
      {
        "v": "positive", 
        "po": 87, 
        "n": "polarity"
      }, 
      {
        "v": "0.65", 
        "po": 87, 
        "n": "Belief score"
      }, 
      {
        "v": "From November 2012 to October 2015 we have selected 43 BRAF mutated, metastatic melanoma patients, treated with vemurafenib.", 
        "po": 87, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Activation", 
          "subj": {
            "name": "vemurafenib", 
            "db_refs": {
              "TEXT": "vemurafenib", 
              "CHEBI": "CHEBI:63637", 
              "PUBCHEM": "42611257"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000459"
          }, 
          "obj": {
            "name": "BRAF", 
            "db_refs": {
              "TEXT": "BRAF", 
              "UP": "P15056", 
              "HGNC": "1097"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000643"
          }, 
          "obj_activity": "activity", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28963614", 
              "text": "From November 2012 to October 2015 we have selected 43 BRAF mutated, metastatic melanoma patients, treated with vemurafenib.", 
              "annotations": {
                "found_by": "Positive_activation_surface_treated_with"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "2157d53e-94d4-424c-99eb-754e1beb7a6d", 
          "sbo": "http://identifiers.org/sbo/SBO:0000182"
        }, 
        "po": 87, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 87, 
        "n": "supportType"
      }, 
      {
        "v": "Complex(RAF1(), BRAF())", 
        "po": 90, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Complex\", \"members\": [{\"name\": \"RAF1\", \"db_refs\": {\"TEXT\": \"CRAF\", \"UP\": \"P04049\", \"HGNC\": \"9829\"}}, {\"name\": \"BRAF\", \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}}], \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"However, kinase impairing BRAF mutations still induce ERK pathway activation when wild-type CRAF, a hetero-dimerization partner of BRAF, is also present in the cell [XREF_BIBR].\", \"annotations\": {\"cell_type\": null, \"organ\": null, \"found_by\": \"binding_19\", \"tissue\": null, \"location\": null, \"cell_line\": null, \"species\": [\"taxonomy:9606\"]}, \"epistemics\": {\"section_type\": null, \"direct\": true}}], \"id\": \"aa33b60b-1dfd-43c7-8fd4-e0af85bdf988\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000526\"}", 
        "po": 90, 
        "n": "INDRA json"
      }, 
      {
        "v": "Complex", 
        "po": 90, 
        "n": "type"
      }, 
      {
        "v": "none", 
        "po": 90, 
        "n": "polarity"
      }, 
      {
        "v": "0.65", 
        "po": 90, 
        "n": "Belief score"
      }, 
      {
        "v": "However, kinase impairing BRAF mutations still induce ERK pathway activation when wild-type CRAF, a hetero-dimerization partner of BRAF, is also present in the cell [XREF_BIBR].", 
        "po": 90, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Complex", 
          "members": [
            {
              "name": "RAF1", 
              "db_refs": {
                "TEXT": "CRAF", 
                "UP": "P04049", 
                "HGNC": "9829"
              }
            }, 
            {
              "name": "BRAF", 
              "db_refs": {
                "TEXT": "BRAF", 
                "UP": "P15056", 
                "HGNC": "1097"
              }
            }
          ], 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "However, kinase impairing BRAF mutations still induce ERK pathway activation when wild-type CRAF, a hetero-dimerization partner of BRAF, is also present in the cell [XREF_BIBR].", 
              "annotations": {
                "cell_type": null, 
                "organ": null, 
                "found_by": "binding_19", 
                "tissue": null, 
                "location": null, 
                "cell_line": null, 
                "species": [
                  "taxonomy:9606"
                ]
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": true
              }
            }
          ], 
          "id": "aa33b60b-1dfd-43c7-8fd4-e0af85bdf988", 
          "sbo": "http://identifiers.org/sbo/SBO:0000526"
        }, 
        "po": 90, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 90, 
        "n": "supportType"
      }, 
      {
        "v": "Inhibition(BRAF(muts: (None, None, None)), ERK())", 
        "po": 93, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Inhibition\", \"subj\": {\"name\": \"BRAF\", \"mutations\": [{\"position\": null, \"residue_from\": null, \"residue_to\": null}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000020\"}, \"obj\": {\"name\": \"ERK\", \"db_refs\": {\"TEXT\": \"ERK\", \"BE\": \"ERK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000642\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"As previously reported, kinase impaired BRAF mutants can still activate the ERK pathway in a CRAF dependent manner [XREF_BIBR].\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}, {\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"Inhibitory effect of Dabrafenib on mutant BRAF induced ERK signaling.\", \"annotations\": {\"found_by\": \"Positive_early_activation\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}, {\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"Inhibitory effect of Trametinib on mutant BRAF induced ERK signaling.\", \"annotations\": {\"found_by\": \"Positive_early_activation\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"7b9004b3-1185-42aa-b3bc-cb6376afeed6\", \"supported_by\": [\"8801cc23-52d0-47aa-9f50-90150a675b3d\", \"25cc8002-0c51-42cf-ad7b-4a2b0cd922da\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}", 
        "po": 93, 
        "n": "INDRA json"
      }, 
      {
        "v": "Inhibition", 
        "po": 93, 
        "n": "type"
      }, 
      {
        "v": "negative", 
        "po": 93, 
        "n": "polarity"
      }, 
      {
        "v": "0.92", 
        "po": 93, 
        "n": "Belief score"
      }, 
      {
        "v": "As previously reported, kinase impaired BRAF mutants can still activate the ERK pathway in a CRAF dependent manner [XREF_BIBR].", 
        "po": 93, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Inhibition", 
          "subj": {
            "name": "BRAF", 
            "mutations": [
              {
                "position": null, 
                "residue_from": null, 
                "residue_to": null
              }
            ], 
            "db_refs": {
              "TEXT": "BRAF", 
              "UP": "P15056", 
              "HGNC": "1097"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000020"
          }, 
          "obj": {
            "name": "ERK", 
            "db_refs": {
              "TEXT": "ERK", 
              "BE": "ERK"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000642"
          }, 
          "obj_activity": "activity", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "As previously reported, kinase impaired BRAF mutants can still activate the ERK pathway in a CRAF dependent manner [XREF_BIBR].", 
              "annotations": {
                "found_by": "Positive_activation_syntax_1_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }, 
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "Inhibitory effect of Dabrafenib on mutant BRAF induced ERK signaling.", 
              "annotations": {
                "found_by": "Positive_early_activation"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }, 
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "Inhibitory effect of Trametinib on mutant BRAF induced ERK signaling.", 
              "annotations": {
                "found_by": "Positive_early_activation"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "7b9004b3-1185-42aa-b3bc-cb6376afeed6", 
          "supported_by": [
            "8801cc23-52d0-47aa-9f50-90150a675b3d", 
            "25cc8002-0c51-42cf-ad7b-4a2b0cd922da"
          ], 
          "sbo": "http://identifiers.org/sbo/SBO:0000182"
        }, 
        "po": 93, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 93, 
        "n": "supportType"
      }, 
      {
        "v": "Inhibition(BRAF(), MEK())", 
        "po": 98, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Inhibition\", \"subj\": {\"name\": \"BRAF\", \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000020\"}, \"obj\": {\"name\": \"MEK\", \"db_refs\": {\"TEXT\": \"MEK\", \"BE\": \"MEK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000642\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"Co-expression of kinase impaired BRAF and CRAF induces MEK and ERK pathway activation in HEK293T cells.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"32b9b643-213e-45f3-b979-f3fc5c82fcde\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}", 
        "po": 98, 
        "n": "INDRA json"
      }, 
      {
        "v": "Inhibition", 
        "po": 98, 
        "n": "type"
      }, 
      {
        "v": "negative", 
        "po": 98, 
        "n": "polarity"
      }, 
      {
        "v": "0.65", 
        "po": 98, 
        "n": "Belief score"
      }, 
      {
        "v": "Co-expression of kinase impaired BRAF and CRAF induces MEK and ERK pathway activation in HEK293T cells.", 
        "po": 98, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Inhibition", 
          "subj": {
            "name": "BRAF", 
            "db_refs": {
              "TEXT": "BRAF", 
              "UP": "P15056", 
              "HGNC": "1097"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000020"
          }, 
          "obj": {
            "name": "MEK", 
            "db_refs": {
              "TEXT": "MEK", 
              "BE": "MEK"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000642"
          }, 
          "obj_activity": "activity", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "Co-expression of kinase impaired BRAF and CRAF induces MEK and ERK pathway activation in HEK293T cells.", 
              "annotations": {
                "found_by": "Positive_activation_syntax_1_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "32b9b643-213e-45f3-b979-f3fc5c82fcde", 
          "sbo": "http://identifiers.org/sbo/SBO:0000182"
        }, 
        "po": 98, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 98, 
        "n": "supportType"
      }, 
      {
        "v": "Inhibition(Dabrafenib(), BRAF())", 
        "po": 102, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Inhibition\", \"subj\": {\"name\": \"Dabrafenib\", \"db_refs\": {\"PUBCHEM\": \"44462760\", \"TEXT\": \"Dabrafenib\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000020\"}, \"obj\": {\"name\": \"BRAF\", \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000642\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"Combination of Dabrafenib and Trametinib enhances and prolongs ERK inhibition in non V600 BRAF mutated cell lines.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"39d890f3-31eb-4d3d-a2ca-4042415f5a38\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}", 
        "po": 102, 
        "n": "INDRA json"
      }, 
      {
        "v": "Inhibition", 
        "po": 102, 
        "n": "type"
      }, 
      {
        "v": "negative", 
        "po": 102, 
        "n": "polarity"
      }, 
      {
        "v": "0.65", 
        "po": 102, 
        "n": "Belief score"
      }, 
      {
        "v": "Combination of Dabrafenib and Trametinib enhances and prolongs ERK inhibition in non V600 BRAF mutated cell lines.", 
        "po": 102, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Inhibition", 
          "subj": {
            "name": "Dabrafenib", 
            "db_refs": {
              "PUBCHEM": "44462760", 
              "TEXT": "Dabrafenib"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000020"
          }, 
          "obj": {
            "name": "BRAF", 
            "db_refs": {
              "TEXT": "BRAF", 
              "UP": "P15056", 
              "HGNC": "1097"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000642"
          }, 
          "obj_activity": "activity", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "Combination of Dabrafenib and Trametinib enhances and prolongs ERK inhibition in non V600 BRAF mutated cell lines.", 
              "annotations": {
                "found_by": "Positive_activation_syntax_1_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "39d890f3-31eb-4d3d-a2ca-4042415f5a38", 
          "sbo": "http://identifiers.org/sbo/SBO:0000182"
        }, 
        "po": 102, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 102, 
        "n": "supportType"
      }, 
      {
        "v": "Inhibition(Dabrafenib(), RAF1())", 
        "po": 105, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Inhibition\", \"subj\": {\"name\": \"Dabrafenib\", \"db_refs\": {\"PUBCHEM\": \"44462760\", \"TEXT\": \"Dabrafenib\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000020\"}, \"obj\": {\"name\": \"RAF1\", \"db_refs\": {\"TEXT\": \"CRAF\", \"UP\": \"P04049\", \"HGNC\": \"9829\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000642\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"The IC50 of Dabrafenib to inhibit CRAF is ~ 10-fold less than that of Vemurafenib [XREF_BIBR - XREF_BIBR].\", \"annotations\": {\"found_by\": \"Negative_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"6eb20af6-42c9-4209-9bb3-681d8716ba18\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}", 
        "po": 105, 
        "n": "INDRA json"
      }, 
      {
        "v": "Inhibition", 
        "po": 105, 
        "n": "type"
      }, 
      {
        "v": "negative", 
        "po": 105, 
        "n": "polarity"
      }, 
      {
        "v": "0.65", 
        "po": 105, 
        "n": "Belief score"
      }, 
      {
        "v": "The IC50 of Dabrafenib to inhibit CRAF is ~ 10-fold less than that of Vemurafenib [XREF_BIBR - XREF_BIBR].", 
        "po": 105, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Inhibition", 
          "subj": {
            "name": "Dabrafenib", 
            "db_refs": {
              "PUBCHEM": "44462760", 
              "TEXT": "Dabrafenib"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000020"
          }, 
          "obj": {
            "name": "RAF1", 
            "db_refs": {
              "TEXT": "CRAF", 
              "UP": "P04049", 
              "HGNC": "9829"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000642"
          }, 
          "obj_activity": "activity", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "The IC50 of Dabrafenib to inhibit CRAF is ~ 10-fold less than that of Vemurafenib [XREF_BIBR - XREF_BIBR].", 
              "annotations": {
                "found_by": "Negative_activation_syntax_1_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "6eb20af6-42c9-4209-9bb3-681d8716ba18", 
          "sbo": "http://identifiers.org/sbo/SBO:0000182"
        }, 
        "po": 105, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 105, 
        "n": "supportType"
      }, 
      {
        "v": "Inhibition(RAF1(), ERK())", 
        "po": 108, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Inhibition\", \"subj\": {\"name\": \"RAF1\", \"db_refs\": {\"TEXT\": \"CRAF\", \"UP\": \"P04049\", \"HGNC\": \"9829\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000020\"}, \"obj\": {\"name\": \"ERK\", \"db_refs\": {\"TEXT\": \"ERK\", \"BE\": \"ERK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000642\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"The study reveals that two MEK inhibitors (Selumetinib and PD0325901) are less efficient than Trametinib for sustained suppression of CRAF mediated ERK activity.\", \"annotations\": {\"found_by\": \"Positive_early_activation\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}, {\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"Co-expression of kinase impaired BRAF and CRAF induces MEK and ERK pathway activation in HEK293T cells.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"6c1d5376-3224-4bd5-96ad-ecedd7d1c54c\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}", 
        "po": 108, 
        "n": "INDRA json"
      }, 
      {
        "v": "Inhibition", 
        "po": 108, 
        "n": "type"
      }, 
      {
        "v": "negative", 
        "po": 108, 
        "n": "polarity"
      }, 
      {
        "v": "0.86", 
        "po": 108, 
        "n": "Belief score"
      }, 
      {
        "v": "The study reveals that two MEK inhibitors (Selumetinib and PD0325901) are less efficient than Trametinib for sustained suppression of CRAF mediated ERK activity.", 
        "po": 108, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Inhibition", 
          "subj": {
            "name": "RAF1", 
            "db_refs": {
              "TEXT": "CRAF", 
              "UP": "P04049", 
              "HGNC": "9829"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000020"
          }, 
          "obj": {
            "name": "ERK", 
            "db_refs": {
              "TEXT": "ERK", 
              "BE": "ERK"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000642"
          }, 
          "obj_activity": "activity", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "The study reveals that two MEK inhibitors (Selumetinib and PD0325901) are less efficient than Trametinib for sustained suppression of CRAF mediated ERK activity.", 
              "annotations": {
                "found_by": "Positive_early_activation"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }, 
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "Co-expression of kinase impaired BRAF and CRAF induces MEK and ERK pathway activation in HEK293T cells.", 
              "annotations": {
                "found_by": "Positive_activation_syntax_1_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "6c1d5376-3224-4bd5-96ad-ecedd7d1c54c", 
          "sbo": "http://identifiers.org/sbo/SBO:0000182"
        }, 
        "po": 108, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 108, 
        "n": "supportType"
      }, 
      {
        "v": "Inhibition(RAF1(), MEK())", 
        "po": 112, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Inhibition\", \"subj\": {\"name\": \"RAF1\", \"db_refs\": {\"TEXT\": \"CRAF\", \"UP\": \"P04049\", \"HGNC\": \"9829\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000020\"}, \"obj\": {\"name\": \"MEK\", \"db_refs\": {\"TEXT\": \"MEK\", \"BE\": \"MEK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000642\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"Co-expression of kinase impaired BRAF and CRAF induces MEK and ERK pathway activation in HEK293T cells.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"0db1c1bb-c7ab-47d2-a7ee-2ccb763f29d5\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}", 
        "po": 112, 
        "n": "INDRA json"
      }, 
      {
        "v": "Inhibition", 
        "po": 112, 
        "n": "type"
      }, 
      {
        "v": "negative", 
        "po": 112, 
        "n": "polarity"
      }, 
      {
        "v": "0.65", 
        "po": 112, 
        "n": "Belief score"
      }, 
      {
        "v": "Co-expression of kinase impaired BRAF and CRAF induces MEK and ERK pathway activation in HEK293T cells.", 
        "po": 112, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Inhibition", 
          "subj": {
            "name": "RAF1", 
            "db_refs": {
              "TEXT": "CRAF", 
              "UP": "P04049", 
              "HGNC": "9829"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000020"
          }, 
          "obj": {
            "name": "MEK", 
            "db_refs": {
              "TEXT": "MEK", 
              "BE": "MEK"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000642"
          }, 
          "obj_activity": "activity", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "Co-expression of kinase impaired BRAF and CRAF induces MEK and ERK pathway activation in HEK293T cells.", 
              "annotations": {
                "found_by": "Positive_activation_syntax_1_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "0db1c1bb-c7ab-47d2-a7ee-2ccb763f29d5", 
          "sbo": "http://identifiers.org/sbo/SBO:0000182"
        }, 
        "po": 112, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 112, 
        "n": "supportType"
      }, 
      {
        "v": "Inhibition(RAF1(), RAF_inhibitors())", 
        "po": 115, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Inhibition\", \"subj\": {\"name\": \"RAF1\", \"db_refs\": {\"TEXT\": \"CRAF\", \"UP\": \"P04049\", \"HGNC\": \"9829\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000020\"}, \"obj\": {\"name\": \"RAF_inhibitors\", \"db_refs\": {\"TEXT\": \"RAF inhibitors\", \"CHEBI\": \"CHEBI:75047\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000642\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"Therefore, it has yet to be determined whether over time activated CRAF can contribute to kinase independent resistance mechanisms to RAF inhibitors in BRAF mutated cancers [XREF_BIBR].\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_7_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"a9427ab8-7862-47ac-80ec-4e99bafb098a\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}", 
        "po": 115, 
        "n": "INDRA json"
      }, 
      {
        "v": "Inhibition", 
        "po": 115, 
        "n": "type"
      }, 
      {
        "v": "negative", 
        "po": 115, 
        "n": "polarity"
      }, 
      {
        "v": "0.65", 
        "po": 115, 
        "n": "Belief score"
      }, 
      {
        "v": "Therefore, it has yet to be determined whether over time activated CRAF can contribute to kinase independent resistance mechanisms to RAF inhibitors in BRAF mutated cancers [XREF_BIBR].", 
        "po": 115, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Inhibition", 
          "subj": {
            "name": "RAF1", 
            "db_refs": {
              "TEXT": "CRAF", 
              "UP": "P04049", 
              "HGNC": "9829"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000020"
          }, 
          "obj": {
            "name": "RAF_inhibitors", 
            "db_refs": {
              "TEXT": "RAF inhibitors", 
              "CHEBI": "CHEBI:75047"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000642"
          }, 
          "obj_activity": "activity", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "Therefore, it has yet to be determined whether over time activated CRAF can contribute to kinase independent resistance mechanisms to RAF inhibitors in BRAF mutated cancers [XREF_BIBR].", 
              "annotations": {
                "found_by": "Positive_activation_syntax_7_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "a9427ab8-7862-47ac-80ec-4e99bafb098a", 
          "sbo": "http://identifiers.org/sbo/SBO:0000182"
        }, 
        "po": 115, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 115, 
        "n": "supportType"
      }, 
      {
        "v": "Inhibition(Trametinib(), BRAF())", 
        "po": 119, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Inhibition\", \"subj\": {\"name\": \"Trametinib\", \"db_refs\": {\"PUBCHEM\": \"11707110\", \"TEXT\": \"Trametinib\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000020\"}, \"obj\": {\"name\": \"BRAF\", \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000642\"}, \"obj_activity\": \"activity\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"Combination of Dabrafenib and Trametinib enhances and prolongs ERK inhibition in non V600 BRAF mutated cell lines.\", \"annotations\": {\"found_by\": \"Positive_activation_syntax_1_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"62edbe1c-da19-4fc2-9ce2-4eef86fe1025\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000182\"}", 
        "po": 119, 
        "n": "INDRA json"
      }, 
      {
        "v": "Inhibition", 
        "po": 119, 
        "n": "type"
      }, 
      {
        "v": "negative", 
        "po": 119, 
        "n": "polarity"
      }, 
      {
        "v": "0.65", 
        "po": 119, 
        "n": "Belief score"
      }, 
      {
        "v": "Combination of Dabrafenib and Trametinib enhances and prolongs ERK inhibition in non V600 BRAF mutated cell lines.", 
        "po": 119, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Inhibition", 
          "subj": {
            "name": "Trametinib", 
            "db_refs": {
              "PUBCHEM": "11707110", 
              "TEXT": "Trametinib"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000020"
          }, 
          "obj": {
            "name": "BRAF", 
            "db_refs": {
              "TEXT": "BRAF", 
              "UP": "P15056", 
              "HGNC": "1097"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000642"
          }, 
          "obj_activity": "activity", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "Combination of Dabrafenib and Trametinib enhances and prolongs ERK inhibition in non V600 BRAF mutated cell lines.", 
              "annotations": {
                "found_by": "Positive_activation_syntax_1_verb"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "62edbe1c-da19-4fc2-9ce2-4eef86fe1025", 
          "sbo": "http://identifiers.org/sbo/SBO:0000182"
        }, 
        "po": 119, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 119, 
        "n": "supportType"
      }, 
      {
        "v": "Phosphorylation(BRAF(mods: (modification), muts: (None, None, None)), ERK())", 
        "po": 122, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Phosphorylation\", \"enz\": {\"name\": \"BRAF\", \"mods\": [{\"mod_type\": \"modification\", \"is_modified\": true}], \"mutations\": [{\"position\": null, \"residue_from\": null, \"residue_to\": null}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000460\"}, \"sub\": {\"name\": \"ERK\", \"db_refs\": {\"TEXT\": \"ERK\", \"BE\": \"ERK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000015\"}, \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"Co-expression of BRAF mutants with impaired kinase activity and CRAF strongly increased MEK and ERK phosphorylation.\", \"annotations\": {\"cell_type\": null, \"organ\": null, \"found_by\": \"Phosphorylation_syntax_4_noun\", \"tissue\": null, \"location\": null, \"cell_line\": [\"cellosaurus:CVCL_0045\"], \"species\": [\"taxonomy:9606\"]}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"3c8c9c9f-91e7-419f-8738-b9529e7570b7\", \"supported_by\": [\"253bfc59-b6d9-4de2-9497-c1a219083bcb\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000216\"}", 
        "po": 122, 
        "n": "INDRA json"
      }, 
      {
        "v": "Modification", 
        "po": 122, 
        "n": "type"
      }, 
      {
        "v": "positive", 
        "po": 122, 
        "n": "polarity"
      }, 
      {
        "v": "0.65", 
        "po": 122, 
        "n": "Belief score"
      }, 
      {
        "v": "Co-expression of BRAF mutants with impaired kinase activity and CRAF strongly increased MEK and ERK phosphorylation.", 
        "po": 122, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Phosphorylation", 
          "enz": {
            "name": "BRAF", 
            "mods": [
              {
                "mod_type": "modification", 
                "is_modified": true
              }
            ], 
            "mutations": [
              {
                "position": null, 
                "residue_from": null, 
                "residue_to": null
              }
            ], 
            "db_refs": {
              "TEXT": "BRAF", 
              "UP": "P15056", 
              "HGNC": "1097"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000460"
          }, 
          "sub": {
            "name": "ERK", 
            "db_refs": {
              "TEXT": "ERK", 
              "BE": "ERK"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000015"
          }, 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "Co-expression of BRAF mutants with impaired kinase activity and CRAF strongly increased MEK and ERK phosphorylation.", 
              "annotations": {
                "cell_type": null, 
                "organ": null, 
                "found_by": "Phosphorylation_syntax_4_noun", 
                "tissue": null, 
                "location": null, 
                "cell_line": [
                  "cellosaurus:CVCL_0045"
                ], 
                "species": [
                  "taxonomy:9606"
                ]
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "3c8c9c9f-91e7-419f-8738-b9529e7570b7", 
          "supported_by": [
            "253bfc59-b6d9-4de2-9497-c1a219083bcb"
          ], 
          "sbo": "http://identifiers.org/sbo/SBO:0000216"
        }, 
        "po": 122, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 122, 
        "n": "supportType"
      }, 
      {
        "v": "Phosphorylation(BRAF(mods: (modification), muts: (None, None, None)), MEK())", 
        "po": 125, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Phosphorylation\", \"enz\": {\"name\": \"BRAF\", \"mods\": [{\"mod_type\": \"modification\", \"is_modified\": true}], \"mutations\": [{\"position\": null, \"residue_from\": null, \"residue_to\": null}], \"db_refs\": {\"TEXT\": \"BRAF\", \"UP\": \"P15056\", \"HGNC\": \"1097\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000460\"}, \"sub\": {\"name\": \"MEK\", \"db_refs\": {\"TEXT\": \"MEK\", \"BE\": \"MEK\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000015\"}, \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"Co-expression of BRAF mutants with impaired kinase activity and CRAF strongly increased MEK and ERK phosphorylation.\", \"annotations\": {\"cell_type\": null, \"organ\": null, \"found_by\": \"Phosphorylation_syntax_4_noun\", \"tissue\": null, \"location\": null, \"cell_line\": [\"cellosaurus:CVCL_0045\"], \"species\": [\"taxonomy:9606\"]}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"96bc8290-e868-43f0-9ba1-1d6238924245\", \"supported_by\": [\"d298a9d6-568f-4abb-84da-1b2060a0b327\"], \"sbo\": \"http://identifiers.org/sbo/SBO:0000216\"}", 
        "po": 125, 
        "n": "INDRA json"
      }, 
      {
        "v": "Modification", 
        "po": 125, 
        "n": "type"
      }, 
      {
        "v": "positive", 
        "po": 125, 
        "n": "polarity"
      }, 
      {
        "v": "0.65", 
        "po": 125, 
        "n": "Belief score"
      }, 
      {
        "v": "Co-expression of BRAF mutants with impaired kinase activity and CRAF strongly increased MEK and ERK phosphorylation.", 
        "po": 125, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Phosphorylation", 
          "enz": {
            "name": "BRAF", 
            "mods": [
              {
                "mod_type": "modification", 
                "is_modified": true
              }
            ], 
            "mutations": [
              {
                "position": null, 
                "residue_from": null, 
                "residue_to": null
              }
            ], 
            "db_refs": {
              "TEXT": "BRAF", 
              "UP": "P15056", 
              "HGNC": "1097"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000460"
          }, 
          "sub": {
            "name": "MEK", 
            "db_refs": {
              "TEXT": "MEK", 
              "BE": "MEK"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000015"
          }, 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "Co-expression of BRAF mutants with impaired kinase activity and CRAF strongly increased MEK and ERK phosphorylation.", 
              "annotations": {
                "cell_type": null, 
                "organ": null, 
                "found_by": "Phosphorylation_syntax_4_noun", 
                "tissue": null, 
                "location": null, 
                "cell_line": [
                  "cellosaurus:CVCL_0045"
                ], 
                "species": [
                  "taxonomy:9606"
                ]
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "96bc8290-e868-43f0-9ba1-1d6238924245", 
          "supported_by": [
            "d298a9d6-568f-4abb-84da-1b2060a0b327"
          ], 
          "sbo": "http://identifiers.org/sbo/SBO:0000216"
        }, 
        "po": 125, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 125, 
        "n": "supportType"
      }, 
      {
        "v": "Phosphorylation(Dabrafenib(), RAF1(), S, 338)", 
        "po": 128, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Phosphorylation\", \"enz\": {\"name\": \"Dabrafenib\", \"db_refs\": {\"PUBCHEM\": \"44462760\", \"TEXT\": \"Dabrafenib\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000460\"}, \"sub\": {\"name\": \"RAF1\", \"db_refs\": {\"TEXT\": \"CRAF\", \"UP\": \"P04049\", \"HGNC\": \"9829\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000015\"}, \"residue\": \"S\", \"position\": \"338\", \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28947956\", \"text\": \"We observed that Dabrafenib treatment of all HEK293T transfectants resulted in phosphorylation of the transfected CRAF molecule at S338, irrespective of the presence and type of BRAF molecule.\", \"annotations\": {\"found_by\": \"Phosphorylation_syntax_1a_noun\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"b7b02426-f9dd-4dd8-b623-52315acdcf48\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000216\"}", 
        "po": 128, 
        "n": "INDRA json"
      }, 
      {
        "v": "Modification", 
        "po": 128, 
        "n": "type"
      }, 
      {
        "v": "positive", 
        "po": 128, 
        "n": "polarity"
      }, 
      {
        "v": "0.65", 
        "po": 128, 
        "n": "Belief score"
      }, 
      {
        "v": "We observed that Dabrafenib treatment of all HEK293T transfectants resulted in phosphorylation of the transfected CRAF molecule at S338, irrespective of the presence and type of BRAF molecule.", 
        "po": 128, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Phosphorylation", 
          "enz": {
            "name": "Dabrafenib", 
            "db_refs": {
              "PUBCHEM": "44462760", 
              "TEXT": "Dabrafenib"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000460"
          }, 
          "sub": {
            "name": "RAF1", 
            "db_refs": {
              "TEXT": "CRAF", 
              "UP": "P04049", 
              "HGNC": "9829"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000015"
          }, 
          "residue": "S", 
          "position": "338", 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28947956", 
              "text": "We observed that Dabrafenib treatment of all HEK293T transfectants resulted in phosphorylation of the transfected CRAF molecule at S338, irrespective of the presence and type of BRAF molecule.", 
              "annotations": {
                "found_by": "Phosphorylation_syntax_1a_noun"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "b7b02426-f9dd-4dd8-b623-52315acdcf48", 
          "sbo": "http://identifiers.org/sbo/SBO:0000216"
        }, 
        "po": 128, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 128, 
        "n": "supportType"
      }, 
      {
        "v": "Phosphorylation(KSR1(), RAF())", 
        "po": 132, 
        "n": "INDRA statement"
      }, 
      {
        "v": "{\"type\": \"Phosphorylation\", \"enz\": {\"name\": \"KSR1\", \"db_refs\": {\"TEXT\": \"KSR1\", \"UP\": \"Q8IVT5\", \"HGNC\": \"6465\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000460\"}, \"sub\": {\"name\": \"RAF\", \"db_refs\": {\"TEXT\": \"RAF\", \"BE\": \"RAF\"}, \"sbo\": \"http://identifiers.org/sbo/SBO:0000015\"}, \"evidence\": [{\"source_api\": \"reach\", \"pmid\": \"28959611\", \"text\": \"Of the five up-regulated genes, P21 and P19 encode for inhibitors for the cyclin D and the CDK4/6 complex; CFOS and CJUN are down stream of ERK and JNK kinases, and KSR1 promotes MEK and RAF phosphorylation.\", \"annotations\": {\"found_by\": \"Phosphorylation_syntax_4_noun\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"id\": \"d475a8bc-a2eb-4898-a6d4-34a412323171\", \"sbo\": \"http://identifiers.org/sbo/SBO:0000216\"}", 
        "po": 132, 
        "n": "INDRA json"
      }, 
      {
        "v": "Modification", 
        "po": 132, 
        "n": "type"
      }, 
      {
        "v": "positive", 
        "po": 132, 
        "n": "polarity"
      }, 
      {
        "v": "0.65", 
        "po": 132, 
        "n": "Belief score"
      }, 
      {
        "v": "Of the five up-regulated genes, P21 and P19 encode for inhibitors for the cyclin D and the CDK4/6 complex; CFOS and CJUN are down stream of ERK and JNK kinases, and KSR1 promotes MEK and RAF phosphorylation.", 
        "po": 132, 
        "n": "Text"
      }, 
      {
        "v": {
          "type": "Phosphorylation", 
          "enz": {
            "name": "KSR1", 
            "db_refs": {
              "TEXT": "KSR1", 
              "UP": "Q8IVT5", 
              "HGNC": "6465"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000460"
          }, 
          "sub": {
            "name": "RAF", 
            "db_refs": {
              "TEXT": "RAF", 
              "BE": "RAF"
            }, 
            "sbo": "http://identifiers.org/sbo/SBO:0000015"
          }, 
          "evidence": [
            {
              "source_api": "reach", 
              "pmid": "28959611", 
              "text": "Of the five up-regulated genes, P21 and P19 encode for inhibitors for the cyclin D and the CDK4/6 complex; CFOS and CJUN are down stream of ERK and JNK kinases, and KSR1 promotes MEK and RAF phosphorylation.", 
              "annotations": {
                "found_by": "Phosphorylation_syntax_4_noun"
              }, 
              "epistemics": {
                "section_type": null, 
                "direct": false
              }
            }
          ], 
          "id": "d475a8bc-a2eb-4898-a6d4-34a412323171", 
          "sbo": "http://identifiers.org/sbo/SBO:0000216"
        }, 
        "po": 132, 
        "n": "indra"
      }, 
      {
        "v": "literature", 
        "po": 132, 
        "n": "supportType"
      }
    ]
  }, 
  {
    "edges": [
      {
        "i": "Activation", 
        "s": 0, 
        "@id": 2, 
        "t": 1
      }, 
      {
        "i": "Activation", 
        "s": 0, 
        "@id": 6, 
        "t": 5
      }, 
      {
        "i": "Activation", 
        "s": 0, 
        "@id": 9, 
        "t": 1
      }, 
      {
        "i": "Activation", 
        "s": 0, 
        "@id": 12, 
        "t": 5
      }, 
      {
        "i": "Activation", 
        "s": 0, 
        "@id": 15, 
        "t": 1
      }, 
      {
        "i": "Activation", 
        "s": 0, 
        "@id": 18, 
        "t": 5
      }, 
      {
        "i": "Activation", 
        "s": 0, 
        "@id": 21, 
        "t": 1
      }, 
      {
        "i": "Activation", 
        "s": 0, 
        "@id": 24, 
        "t": 5
      }, 
      {
        "i": "Activation", 
        "s": 0, 
        "@id": 27, 
        "t": 1
      }, 
      {
        "i": "Activation", 
        "s": 0, 
        "@id": 30, 
        "t": 5
      }, 
      {
        "i": "Activation", 
        "s": 0, 
        "@id": 33, 
        "t": 1
      }, 
      {
        "i": "Activation", 
        "s": 0, 
        "@id": 37, 
        "t": 5
      }, 
      {
        "i": "Activation", 
        "s": 0, 
        "@id": 40, 
        "t": 1
      }, 
      {
        "i": "Activation", 
        "s": 0, 
        "@id": 43, 
        "t": 5
      }, 
      {
        "i": "Activation", 
        "s": 0, 
        "@id": 46, 
        "t": 1
      }, 
      {
        "i": "Activation", 
        "s": 0, 
        "@id": 51, 
        "t": 50
      }, 
      {
        "i": "Activation", 
        "s": 0, 
        "@id": 55, 
        "t": 54
      }, 
      {
        "i": "Activation", 
        "s": 0, 
        "@id": 60, 
        "t": 59
      }, 
      {
        "i": "Activation", 
        "s": 63, 
        "@id": 64, 
        "t": 0
      }, 
      {
        "i": "Activation", 
        "s": 1, 
        "@id": 67, 
        "t": 54
      }, 
      {
        "i": "Activation", 
        "s": 71, 
        "@id": 72, 
        "t": 0
      }, 
      {
        "i": "Activation", 
        "s": 54, 
        "@id": 75, 
        "t": 1
      }, 
      {
        "i": "Activation", 
        "s": 81, 
        "@id": 83, 
        "t": 82
      }, 
      {
        "i": "Activation", 
        "s": 86, 
        "@id": 87, 
        "t": 0
      }, 
      {
        "i": "Complex", 
        "s": 54, 
        "@id": 90, 
        "t": 0
      }, 
      {
        "i": "Inhibition", 
        "s": 0, 
        "@id": 93, 
        "t": 1
      }, 
      {
        "i": "Inhibition", 
        "s": 0, 
        "@id": 98, 
        "t": 5
      }, 
      {
        "i": "Inhibition", 
        "s": 101, 
        "@id": 102, 
        "t": 0
      }, 
      {
        "i": "Inhibition", 
        "s": 101, 
        "@id": 105, 
        "t": 54
      }, 
      {
        "i": "Inhibition", 
        "s": 54, 
        "@id": 108, 
        "t": 1
      }, 
      {
        "i": "Inhibition", 
        "s": 54, 
        "@id": 112, 
        "t": 5
      }, 
      {
        "i": "Inhibition", 
        "s": 54, 
        "@id": 115, 
        "t": 81
      }, 
      {
        "i": "Inhibition", 
        "s": 118, 
        "@id": 119, 
        "t": 0
      }, 
      {
        "i": "Phosphorylation", 
        "s": 0, 
        "@id": 122, 
        "t": 1
      }, 
      {
        "i": "Phosphorylation", 
        "s": 0, 
        "@id": 125, 
        "t": 5
      }, 
      {
        "i": "Phosphorylation", 
        "s": 101, 
        "@id": 128, 
        "t": 54
      }, 
      {
        "i": "Phosphorylation", 
        "s": 131, 
        "@id": 132, 
        "t": 82
      }
    ]
  }, 
  {
    "edgeSupports": [
      {
        "supports": [
          4
        ], 
        "po": [
          2
        ]
      }, 
      {
        "supports": [
          8
        ], 
        "po": [
          6
        ]
      }, 
      {
        "supports": [
          11
        ], 
        "po": [
          9
        ]
      }, 
      {
        "supports": [
          14
        ], 
        "po": [
          12
        ]
      }, 
      {
        "supports": [
          17
        ], 
        "po": [
          15
        ]
      }, 
      {
        "supports": [
          20
        ], 
        "po": [
          18
        ]
      }, 
      {
        "supports": [
          23
        ], 
        "po": [
          21
        ]
      }, 
      {
        "supports": [
          26
        ], 
        "po": [
          24
        ]
      }, 
      {
        "supports": [
          29
        ], 
        "po": [
          27
        ]
      }, 
      {
        "supports": [
          32
        ], 
        "po": [
          30
        ]
      }, 
      {
        "supports": [
          35, 
          36
        ], 
        "po": [
          33
        ]
      }, 
      {
        "supports": [
          39
        ], 
        "po": [
          37
        ]
      }, 
      {
        "supports": [
          42
        ], 
        "po": [
          40
        ]
      }, 
      {
        "supports": [
          45
        ], 
        "po": [
          43
        ]
      }, 
      {
        "supports": [
          48, 
          49
        ], 
        "po": [
          46
        ]
      }, 
      {
        "supports": [
          53
        ], 
        "po": [
          51
        ]
      }, 
      {
        "supports": [
          57, 
          58
        ], 
        "po": [
          55
        ]
      }, 
      {
        "supports": [
          62
        ], 
        "po": [
          60
        ]
      }, 
      {
        "supports": [
          66
        ], 
        "po": [
          64
        ]
      }, 
      {
        "supports": [
          69, 
          70
        ], 
        "po": [
          67
        ]
      }, 
      {
        "supports": [
          74
        ], 
        "po": [
          72
        ]
      }, 
      {
        "supports": [
          78, 
          79, 
          80
        ], 
        "po": [
          75
        ]
      }, 
      {
        "supports": [
          85
        ], 
        "po": [
          83
        ]
      }, 
      {
        "supports": [
          89
        ], 
        "po": [
          87
        ]
      }, 
      {
        "supports": [
          92
        ], 
        "po": [
          90
        ]
      }, 
      {
        "supports": [
          95, 
          96, 
          97
        ], 
        "po": [
          93
        ]
      }, 
      {
        "supports": [
          100
        ], 
        "po": [
          98
        ]
      }, 
      {
        "supports": [
          104
        ], 
        "po": [
          102
        ]
      }, 
      {
        "supports": [
          107
        ], 
        "po": [
          105
        ]
      }, 
      {
        "supports": [
          110, 
          111
        ], 
        "po": [
          108
        ]
      }, 
      {
        "supports": [
          114
        ], 
        "po": [
          112
        ]
      }, 
      {
        "supports": [
          117
        ], 
        "po": [
          115
        ]
      }, 
      {
        "supports": [
          121
        ], 
        "po": [
          119
        ]
      }, 
      {
        "supports": [
          124
        ], 
        "po": [
          122
        ]
      }, 
      {
        "supports": [
          127
        ], 
        "po": [
          125
        ]
      }, 
      {
        "supports": [
          130
        ], 
        "po": [
          128
        ]
      }, 
      {
        "supports": [
          134
        ], 
        "po": [
          132
        ]
      }
    ]
  }, 
  {
    "citations": [
      {
        "@id": 3, 
        "dc:identifier": "pmid:28947956"
      }, 
      {
        "@id": 7, 
        "dc:identifier": "pmid:28947956"
      }, 
      {
        "@id": 10, 
        "dc:identifier": "pmid:28947956"
      }, 
      {
        "@id": 13, 
        "dc:identifier": "pmid:28947956"
      }, 
      {
        "@id": 16, 
        "dc:identifier": "pmid:28947956"
      }, 
      {
        "@id": 19, 
        "dc:identifier": "pmid:28947956"
      }, 
      {
        "@id": 22, 
        "dc:identifier": "pmid:28947956"
      }, 
      {
        "@id": 25, 
        "dc:identifier": "pmid:28947956"
      }, 
      {
        "@id": 28, 
        "dc:identifier": "pmid:28947956"
      }, 
      {
        "@id": 31, 
        "dc:identifier": "pmid:28947956"
      }, 
      {
        "@id": 34, 
        "dc:identifier": "pmid:28947956"
      }, 
      {
        "@id": 38, 
        "dc:identifier": "pmid:28947956"
      }, 
      {
        "@id": 41, 
        "dc:identifier": "pmid:28947956"
      }, 
      {
        "@id": 44, 
        "dc:identifier": "pmid:28947956"
      }, 
      {
        "@id": 47, 
        "dc:identifier": "pmid:28986151"
      }, 
      {
        "@id": 52, 
        "dc:identifier": "pmid:28947956"
      }, 
      {
        "@id": 56, 
        "dc:identifier": "pmid:28947956"
      }, 
      {
        "@id": 61, 
        "dc:identifier": "pmid:28986151"
      }, 
      {
        "@id": 65, 
        "dc:identifier": "pmid:28974625"
      }, 
      {
        "@id": 68, 
        "dc:identifier": "pmid:28947956"
      }, 
      {
        "@id": 73, 
        "dc:identifier": "pmid:28916587"
      }, 
      {
        "@id": 76, 
        "dc:identifier": "pmid:28947956"
      }, 
      {
        "@id": 77, 
        "dc:identifier": "pmid:28953887"
      }, 
      {
        "@id": 84, 
        "dc:identifier": "pmid:28951457"
      }, 
      {
        "@id": 88, 
        "dc:identifier": "pmid:28963614"
      }, 
      {
        "@id": 91, 
        "dc:identifier": "pmid:28947956"
      }, 
      {
        "@id": 94, 
        "dc:identifier": "pmid:28947956"
      }, 
      {
        "@id": 99, 
        "dc:identifier": "pmid:28947956"
      }, 
      {
        "@id": 103, 
        "dc:identifier": "pmid:28947956"
      }, 
      {
        "@id": 106, 
        "dc:identifier": "pmid:28947956"
      }, 
      {
        "@id": 109, 
        "dc:identifier": "pmid:28947956"
      }, 
      {
        "@id": 113, 
        "dc:identifier": "pmid:28947956"
      }, 
      {
        "@id": 116, 
        "dc:identifier": "pmid:28947956"
      }, 
      {
        "@id": 120, 
        "dc:identifier": "pmid:28947956"
      }, 
      {
        "@id": 123, 
        "dc:identifier": "pmid:28947956"
      }, 
      {
        "@id": 126, 
        "dc:identifier": "pmid:28947956"
      }, 
      {
        "@id": 129, 
        "dc:identifier": "pmid:28947956"
      }, 
      {
        "@id": 133, 
        "dc:identifier": "pmid:28959611"
      }
    ]
  }, 
  {
    "nodes": [
      {
        "@id": 0, 
        "n": "BRAF"
      }, 
      {
        "@id": 1, 
        "n": "ERK"
      }, 
      {
        "@id": 5, 
        "n": "MEK"
      }, 
      {
        "@id": 50, 
        "n": "KRAS"
      }, 
      {
        "@id": 54, 
        "n": "RAF1"
      }, 
      {
        "@id": 59, 
        "n": "senescence"
      }, 
      {
        "@id": 63, 
        "n": "EGFR"
      }, 
      {
        "@id": 71, 
        "n": "MC1R"
      }, 
      {
        "@id": 81, 
        "n": "RAF_inhibitors"
      }, 
      {
        "@id": 82, 
        "n": "RAF"
      }, 
      {
        "@id": 86, 
        "n": "vemurafenib"
      }, 
      {
        "@id": 101, 
        "n": "Dabrafenib"
      }, 
      {
        "@id": 118, 
        "n": "Trametinib"
      }, 
      {
        "@id": 131, 
        "n": "KSR1"
      }
    ]
  }, 
  {
    "supports": [
      {
        "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
        "@id": 4
      }, 
      {
        "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
        "@id": 8
      }, 
      {
        "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
        "@id": 11
      }, 
      {
        "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
        "@id": 14
      }, 
      {
        "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
        "@id": 17
      }, 
      {
        "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
        "@id": 20
      }, 
      {
        "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
        "@id": 23
      }, 
      {
        "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
        "@id": 26
      }, 
      {
        "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
        "@id": 29
      }, 
      {
        "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
        "@id": 32
      }, 
      {
        "text": "As we observed, D594V BRAF, even in the presence of CRAF, did not induce strong ERK activity.", 
        "@id": 35
      }, 
      {
        "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
        "@id": 36
      }, 
      {
        "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
        "@id": 39
      }, 
      {
        "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
        "@id": 42
      }, 
      {
        "text": "The BRAF mutants G466V, D594A, D594G, D594E, D594N, D594V and G596C did not induce MEK or ERK activation compared to wt-BRAF.", 
        "@id": 45
      }, 
      {
        "text": "The BRAF V600E mutation activates MAPK, affecting cell proliferation, differentiation, and survival.", 
        "@id": 48
      }, 
      {
        "text": "BRAF V600E mutation has been reported to abnormally activate MAPK signal pathway.", 
        "@id": 49
      }, 
      {
        "text": "This result may explain why H1666 and H508 cells are more sensitive to Trametinib than to Selumetinib, as BRAF mutations in these cell lines activate the ERK pathway in a CRAF dependent manner, similarly to KRAS mutated cells.", 
        "@id": 53
      }, 
      {
        "text": "A clinically relevant dose of Dabrafenib, a type I RAF-inhibitor, in HEK293T cells reduced ERK activity induced by BRAF mutations conferring high kinase activity in the presence and absence of CRAF.", 
        "@id": 57
      }, 
      {
        "text": "This result may explain why H1666 and H508 cells are more sensitive to Trametinib than to Selumetinib, as BRAF mutations in these cell lines activate the ERK pathway in a CRAF dependent manner, similarly to KRAS mutated cells.", 
        "@id": 58
      }, 
      {
        "text": "Some studies also found that constitutive BRAF activity induces MAPK activity and glioma genesis in xenografted mice but eventually leads to tumour senescence.", 
        "@id": 62
      }, 
      {
        "text": "Retraction : EGFR Mediated Reactivation of MAPK Signaling Induces Acquired Resistance to GSK2118436 in BRAF V600E-Mutant NSCLC Cell Lines.", 
        "@id": 66
      }, 
      {
        "text": "A clinically relevant dose of Dabrafenib, a type I RAF-inhibitor, in HEK293T cells reduced ERK activity induced by BRAF mutations conferring high kinase activity in the presence and absence of CRAF.", 
        "@id": 69
      }, 
      {
        "text": "In addition, combined Dabrafenib and Trametinib treatment inhibited Dabrafenib induced ERK activation in CRAF overexpressing monotransfectants.", 
        "@id": 70
      }, 
      {
        "text": "Palmitoylation deficient MC1R variants accelerate BRAF (V60E)-driven melanomagenesis.", 
        "@id": 74
      }, 
      {
        "text": "In HEK293T cells, Trametinib modestly decreased ERK activity induced by BRAF mutations conferring elevated kinase activity while strongly inhibited kinase impaired BRAF and CRAF induced ERK activation.", 
        "@id": 78
      }, 
      {
        "text": "A recent study revealed the superior efficacy of Trametinib versus several other MEK-inhibitors in cells with KRAS mutations and CRAF mediated ERK pathway activation [].", 
        "@id": 79
      }, 
      {
        "text": "In BRAFi resistant cells, PAKs phosphorylate CRAF and MEK to reactivate ERK.", 
        "@id": 80
      }, 
      {
        "text": "Currently approved RAF inhibitors inhibit RAF monomers but not dimers.", 
        "@id": 85
      }, 
      {
        "text": "From November 2012 to October 2015 we have selected 43 BRAF mutated, metastatic melanoma patients, treated with vemurafenib.", 
        "@id": 89
      }, 
      {
        "text": "However, kinase impairing BRAF mutations still induce ERK pathway activation when wild-type CRAF, a hetero-dimerization partner of BRAF, is also present in the cell [].", 
        "@id": 92
      }, 
      {
        "text": "As previously reported, kinase impaired BRAF mutants can still activate the ERK pathway in a CRAF dependent manner [].", 
        "@id": 95
      }, 
      {
        "text": "Inhibitory effect of Dabrafenib on mutant BRAF induced ERK signaling.", 
        "@id": 96
      }, 
      {
        "text": "Inhibitory effect of Trametinib on mutant BRAF induced ERK signaling.", 
        "@id": 97
      }, 
      {
        "text": "Co-expression of kinase impaired BRAF and CRAF induces MEK and ERK pathway activation in HEK293T cells.", 
        "@id": 100
      }, 
      {
        "text": "Combination of Dabrafenib and Trametinib enhances and prolongs ERK inhibition in non V600 BRAF mutated cell lines.", 
        "@id": 104
      }, 
      {
        "text": "The IC50 of Dabrafenib to inhibit CRAF is ~ 10-fold less than that of Vemurafenib [ - ].", 
        "@id": 107
      }, 
      {
        "text": "The study reveals that two MEK inhibitors (Selumetinib and PD0325901) are less efficient than Trametinib for sustained suppression of CRAF mediated ERK activity.", 
        "@id": 110
      }, 
      {
        "text": "Co-expression of kinase impaired BRAF and CRAF induces MEK and ERK pathway activation in HEK293T cells.", 
        "@id": 111
      }, 
      {
        "text": "Co-expression of kinase impaired BRAF and CRAF induces MEK and ERK pathway activation in HEK293T cells.", 
        "@id": 114
      }, 
      {
        "text": "Therefore, it has yet to be determined whether over time activated CRAF can contribute to kinase independent resistance mechanisms to RAF inhibitors in BRAF mutated cancers [].", 
        "@id": 117
      }, 
      {
        "text": "Combination of Dabrafenib and Trametinib enhances and prolongs ERK inhibition in non V600 BRAF mutated cell lines.", 
        "@id": 121
      }, 
      {
        "text": "Co-expression of BRAF mutants with impaired kinase activity and CRAF strongly increased MEK and ERK phosphorylation.", 
        "@id": 124
      }, 
      {
        "text": "Co-expression of BRAF mutants with impaired kinase activity and CRAF strongly increased MEK and ERK phosphorylation.", 
        "@id": 127
      }, 
      {
        "text": "We observed that Dabrafenib treatment of all HEK293T transfectants resulted in phosphorylation of the transfected CRAF molecule at S338, irrespective of the presence and type of BRAF molecule.", 
        "@id": 130
      }, 
      {
        "text": "Of the five up-regulated genes, P21 and P19 encode for inhibitors for the cyclin D and the CDK4/6 complex; CFOS and CJUN are down stream of ERK and JNK kinases, and KSR1 promotes MEK and RAF phosphorylation.", 
        "@id": 134
      }
    ]
  }, 
  {
    "edgeCitations": [
      {
        "citations": [
          3
        ], 
        "po": [
          2
        ]
      }, 
      {
        "citations": [
          7
        ], 
        "po": [
          6
        ]
      }, 
      {
        "citations": [
          10
        ], 
        "po": [
          9
        ]
      }, 
      {
        "citations": [
          13
        ], 
        "po": [
          12
        ]
      }, 
      {
        "citations": [
          16
        ], 
        "po": [
          15
        ]
      }, 
      {
        "citations": [
          19
        ], 
        "po": [
          18
        ]
      }, 
      {
        "citations": [
          22
        ], 
        "po": [
          21
        ]
      }, 
      {
        "citations": [
          25
        ], 
        "po": [
          24
        ]
      }, 
      {
        "citations": [
          28
        ], 
        "po": [
          27
        ]
      }, 
      {
        "citations": [
          31
        ], 
        "po": [
          30
        ]
      }, 
      {
        "citations": [
          34
        ], 
        "po": [
          33
        ]
      }, 
      {
        "citations": [
          38
        ], 
        "po": [
          37
        ]
      }, 
      {
        "citations": [
          41
        ], 
        "po": [
          40
        ]
      }, 
      {
        "citations": [
          44
        ], 
        "po": [
          43
        ]
      }, 
      {
        "citations": [
          47
        ], 
        "po": [
          46
        ]
      }, 
      {
        "citations": [
          52
        ], 
        "po": [
          51
        ]
      }, 
      {
        "citations": [
          56
        ], 
        "po": [
          55
        ]
      }, 
      {
        "citations": [
          61
        ], 
        "po": [
          60
        ]
      }, 
      {
        "citations": [
          65
        ], 
        "po": [
          64
        ]
      }, 
      {
        "citations": [
          68
        ], 
        "po": [
          67
        ]
      }, 
      {
        "citations": [
          73
        ], 
        "po": [
          72
        ]
      }, 
      {
        "citations": [
          76, 
          77
        ], 
        "po": [
          75
        ]
      }, 
      {
        "citations": [
          84
        ], 
        "po": [
          83
        ]
      }, 
      {
        "citations": [
          88
        ], 
        "po": [
          87
        ]
      }, 
      {
        "citations": [
          91
        ], 
        "po": [
          90
        ]
      }, 
      {
        "citations": [
          94
        ], 
        "po": [
          93
        ]
      }, 
      {
        "citations": [
          99
        ], 
        "po": [
          98
        ]
      }, 
      {
        "citations": [
          103
        ], 
        "po": [
          102
        ]
      }, 
      {
        "citations": [
          106
        ], 
        "po": [
          105
        ]
      }, 
      {
        "citations": [
          109
        ], 
        "po": [
          108
        ]
      }, 
      {
        "citations": [
          113
        ], 
        "po": [
          112
        ]
      }, 
      {
        "citations": [
          116
        ], 
        "po": [
          115
        ]
      }, 
      {
        "citations": [
          120
        ], 
        "po": [
          119
        ]
      }, 
      {
        "citations": [
          123
        ], 
        "po": [
          122
        ]
      }, 
      {
        "citations": [
          126
        ], 
        "po": [
          125
        ]
      }, 
      {
        "citations": [
          129
        ], 
        "po": [
          128
        ]
      }, 
      {
        "citations": [
          133
        ], 
        "po": [
          132
        ]
      }
    ]
  }, 
  {
    "status": [
      {
        "success": true, 
        "error": ""
      }
    ]
  }
]